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The Prologue to *Bertrand Russell's Autobiography 
What I Have Lived For 
Three passions, simple but overwhelmingly strong, have governed my life: the 
longing for love, the search for knowledge, and unbearable pity for the suffering of 
mankind. These passions, like great winds, have blown me hither and thither, in a 
wayward course, over a great ocean of anguish, reaching to the very verge of despair. 
I have sought love, first, because it brings ecstasy - ecstasy so great that I would 
often have sacrificed all the rest of life for a few hours of this joy. I have sought it, 
next, because it relieves loneliness--that terrible loneliness in which one shivering 
consciousness looks over the rim of the world into the cold unfathomable lifeless 
abyss. I have sought it finally, because in the union of love I have seen, in a mystic 
miniature, the prefiguring vision of the heaven that saints and poets have imagined. 
This is what I sought, and though it might seem too good for human life, this is what--
at last--I have found. 
With equal passion I have sought knowledge. I have wished to understand the 
hearts of men. I have wished to know why the stars shine. And I have tried to 
apprehend the Pythagorean power by which number holds sway above the flux. A 
little of this, but not much, I have achieved. 
Love and knowledge, so far as they were possible, led upward toward the 
heavens. But always pity brought me back to earth. Echoes of cries of pain reverberate 
in my heart. Children in famine, victims tortured by oppressors, helpless old people a 
burden to their sons, and the whole world of loneliness, poverty, and pain make a 
mockery of what human life should be. I long to alleviate this evil, but I cannot, and I 
too suffer. 
This has been my life. I have found it worth living, and would gladly live it again 
if the chance were offered me. 
 
 
 
*Bertrand Russell (1872-1970) won the Nobel prize for literature for his History 
of Western Philosophy and was the co-author of Principia Mathematica. 
(http://www.users.drew.edu/%7Ejlenz/prolog.html) 
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ABSTRACT 
Homocitrate synthase (HCS) catalyzes one of the regulated steps of the α-
aminoadipate pathway for Lys biosynthesis in fungi. His-tagged HCS from 
Saccharomyces cerevisiae was purified to about 98% using a Ni-NTA resin and 
stabilized. The enzyme, in the absence of reactants, self associates, as suggested by 
size exclusion chromatography. Fluorescence and circular dichroic spectra suggested a 
partially exposed Trp residue and a mixed (α/β) secondary structure for the enzyme. 
Fluorescence quenching studies with KI, CsCl, and acrylamide, suggest that the 
microenvironment around the single Trp residue of the enzyme has some positive 
charge. 
Kinetic data have been collected suggesting a preferred sequential ordered 
kinetic mechanism for the His-tagged HCS from S. cerevisiae with α-Kg binding 
before AcCoA and CoA released before Hc. In agreement with the ordered kinetic 
mechanism desulfo-CoA is uncompetitive and citrate is competitive vs α-Kg. Varying 
AcCoA, citrate is a noncompetitive inhibitor as predicted, but CoA is noncompetitive 
vs AcCoA suggesting binding of CoA to E:Hc and E:α-Kg. The product CoA behaves 
identical to desulfo-CoA, suggesting an E:α-Kg:CoA dead-end complex. Data further 
suggest an irreversible reaction overall. Fluorescence titration data show finite binding 
of CoA and AcCoA to free enzyme, suggesting the mechanism may be random with a 
high degree of synergism of binding between the reactants. 
The kinetic mechanism of regulation of HCS from S. cerevisiae by Na+ and the 
feedback inhibitor Lys was studied by measuring the initial rate in the absence and 
 xxi
presence of the effectors. Data suggest that Na+ is an activator at low concentrations 
and an inhibitor at high concentrations, and these effects occur as a result of the 
monovalent ion binding to two different sites in the free enzyme. Inhibition and 
activation by Na+ can occur simultaneously. The inhibition by Na+ is eliminated at 
high concentrations of AcCoA, the second substrate bound, but the activation remains. 
Fluorescence binding studies indicate Lys binds with high affinity to its binding site as 
an inhibitor. The inhibition by Lys is competitive and linear vs α-Kg. The effects of 
Na+ and Lys are independent of one another. A model is developed for regulation of 
HCS that takes into account all of the effects discussed above. The rate equations that 
predict the regulatory kinetic behavior of HCS are also derived, and simulation of the 
predicted behavior is carried out over a range of values for the kinetic parameters. 
Data obtained allow application of the resulting expressions to enzyme systems that 
exhibit activation and inhibition as a result of the interaction of the effectors at 
multiple sites in free enzyme. The HCS is used as an example, in terms of its 
activation by Na+ binding to the active enzyme conformer at an allosteric site, 
inhibition by binding to the active site, and inhibition by Lys binding to the less active 
enzyme conformer. 
In the case of saccharopine reductase (SR), the three-dimensional structure of the 
enzyme from S. cerevisiae, was determined to 1.7 Å resolution in the apo form using 
molecular replacement. The enzyme monomer consists of three domains. Comparative 
fold alignment with the enzyme from Magnaporthe grisea suggests that domain I 
binds to NADPH, domain II binds to saccharopine and is involved in dimer formation. 
 xxii
Domain III is involved in closing the active site of the enzyme once substrates are 
bound. Structural comparison of the SR enzymes from S. cerevisiae and M. grisea 
indicates that domain II has the highest number of conserved residues suggesting that 
it plays an important role in substrate binding and in spatially orienting domains I and 
III. 
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1-1. Amino acid biosynthesis 
In general, most of the living organisms use 20 common amino acids to make 
their protein pools. Biosynthesis of these amino acids can be categorized into six 
major families as follows: 1) the glutamate family for the biosynthesis of Glu, Gln, 
Pro, and Arg; 2) the serine family for the biosynthesis of Ser, Gly and Cys; 3) the 
aspartate family for the biosynthesis of Asp, Asn, Lys, Met, Thr, Ile; 4) the pyruvate 
family for the biosynthesis of Ile, Leu, Val and Ala; 5) the aromatic family for the 
biosynthesis of Phe, Tyr and Trp; and 6) the histidine biosynthetic pathway (1). 
Biosynthetic regulation of the aforementioned amino acids occurs at two distinct 
levels. The first level of regulation occurs at the level of enzyme activity and 
metabolite flow that is the subject of enzymologic studies. The second level of 
regulation occurs via regulation of gene expression that is the subject of molecular 
genetics. Most of the studies of regulation of amino acid biosynthesis have been 
performed in Escherichia coli and Salmonella typhimurium (1). 
The focus of this dissertation is on the α-aminoadipate pathway for lysine 
biosynthesis which is unique to fungi. 
 
 
1
 1-2. Biosynthesis of lysine 
L-lysine is an essential amino acid for humans and animals and can only be 
obtained from protein in the diet. It can be synthesized de novo in bacteria, lower 
eukaryotes, and some plants. Among the 20 common proteinogenic amino acids, L-
lysine is the only one known to have two distinct biosynthetic pathways: the 
diaminopimelate (DAP) pathway in plants, bacteria and lower fungi, and the α-
aminoadipate (AAA) pathway in euglenoids and higher fungi (2). Unlike the pathways 
for lysine synthesis, pathways for other amino acid synthesis are similar in bacteria 
and fungi (1, 3). 
 
1-2-1. Diaminopimelate pathway of L-lysine biosynthesis 
The diaminopimelate pathway is found in most plants, bacteria, and lower fungi, 
and consists of seven enzyme-catalyzed reactions (Fig. 1-1) (1, 5). 
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Fig. 1-1: The enzymes of the lysine DAP biosynthetic pathway are as follows: (1) Aspartate kinase 
(Ask, E.C. 2.7.2.4), (2) Aspartate semialdehyde dehydrogenase (Asd, E.C. 1.2.1.11), (3) 
Dihydrodipicolinate synthase (DapA, E.C. 4.2.1.52), (4) Dihydrodipicolinate reductase (DapB, 
E.C. 1.3.1.26), (5) Tetrahydrodipicolinate acyltransferase (DapD, E.C. 2.3.1.117), (6) N-succinyl-
α-amino-ε-ketopimelate-glutamate aminotransaminase (DapC, E.C. 2.6.1.17), (7) N-
acyldiaminopimelate deacylase (DapE, E.C. 3.5.1.18, E. C. 3.5.1.47), (8) Diaminopimelate 
epimerase (DapF, E.C. 5.1.1.7), (9) Diaminopimelate decarboxylase (LysA, E. C. 4.1.1.20). 
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 It belongs to the aspartate family of amino acid biosynthesis with aspartate as the 
common precursor. This pathway is the source of the diaminopimelate and lysine that 
are incorporated into bacterial cell wall peptidoglycan and transpeptidative cross-
linking. Enzymes in the DAP pathway are therefore targets for developing new 
antibacterial agents (6). 
The pathway begins with the phosphorylation of aspartate by aspartokinase to 
give aspartyl-β-phosphate followed by an NADPH-dependent reduction to give 
aspartate β-semialdehyde. Aldol condensation of aspartate semialdehyde with 
pyruvate yields, upon rearrangement, 2,3-dihydrodipicolinate, which is then reduced 
by NADPH to ∆1-piperideine-2, 6-dicarboxylate. Succinylation (or acetylation) opens 
the ring to give N-succinyl (or acetyl) α-amino-є-ketopimelate. After transamination, 
the acyl group is removed to yield L, L-diaminopimelate, which can be incorporated 
directly into the peptidoglycan, or racemized to the meso compound prior to 
incorporation. Racemization to the meso form is required, since this is the precursor to 
L-lysine, once it is decarboxylated. 
 
1-2-2. α-Aminoadipate pathway of L-Lysine biosynthesis 
The presence of the α-aminoadipate pathway for lysine biosynthesis has been 
demonstrated in several yeasts and molds, including Saccharomyces cerevisiae (4, 7), 
Yarrowia lipolytica (8), Schizosaccharomyces pombe (9), Rhodotorula glutinis (10), 
Candida maltosa (11), Neurospora crassa (12), Penicillium chrysogenum (13), human 
pathogenic fungi, such as Candida albicans (14), Cryptococcus neoformans (15), 
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 Aspergillus fumigatus (15), and plant pathogens, including Magnaporthe grisea (1, 
15). The enzymes from S. cerevisiae are highly similar to their closest homologs from 
C. albicans and A. fumigatus. Multiple sequence alignment shows >60% identity for 
all but one (aminotransferase) of the enzymes in the pathway from those organisms. 
The α-aminoadipate pathway is present only in euglenoids and higher fungi (3-4, 
16-17), with α-ketoglutarate serving as the precursor for L-lysine. This pathway is a 
member of the glutamate family of amino acid biosynthesis, and resembles the 
pathway from glutamate to ornithine in bacterial arginine biosynthesis (18-19). 
Enzymes involved in the fungal α-aminoadipate pathway are unique to lysine 
synthesis (1, 4). 
The Saccharomyces cerevisiae genome has been completely sequenced (20-22). 
Extensive genetic, enzymatic, and regulatory studies of the lysine biosynthetic 
pathway are being carried out in S. cerevisiae (14). Seven enzymes, eight steps and 
more than 12 non-linked genes are responsible for the biosynthesis of lysine in S. 
cerevisiae (4, 23-24). Genes and their encoded enzymes involved in the AAA pathway 
are listed in Table 1-1. The pathway for the de novo synthesis of lysine in fungi is 
shown in Fig. 1-2, and the enzymatic steps are briefly described below. 
Table 1-1: Genes and enzymes involved in the α–aminoadipate pathway in S. cerevisiae. 
Enzyme Gene 
Homocitrate synthase LYS20 (cytosol), LYS21 (mitochondria) 
Homoaconitase LYS4 ( LYS7) 
Homoisocitrate dehydrogenase LYS10 
α-Aminoadipate aminotransferase General aminotransferase 
α -Aminoadipate reductase 
(phosphopantetheinyl transferase) 
LYS2 
(LYS5) 
Saccharopine reductase LYS9 (regulated by LYS14) 
Saccahropine dehydrogenase LYS1 
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Fig. 1-2: The enzymes of the lysine AAA biosynthetic pathway are as follows: (1) Homocitrate 
synthase (HCS, E.C. 4.1.3.21), (2) Homoaconitase (HAc, E.C. 4.2.1.36), (3) Homoisocitrate 
dehydrogenase (HIDH, E.C. 1.1.1.87), (4) α-aminoadipate aminotransferase (AAT, E.C. 2.6.1.39), 
(5) α-aminoadipate reductase (AAR, E.C. 1.2.1.31), (6) Saccharopine reductase (SR, E.C. 
1.5.1.10), (7) Saccharopine dehydrogenase (SDH, E.C. 1.2.1.31). 
 
 
The first half of the pathway, formation of α–aminoadipate from AcCoA and α–
ketoglutarate, takes place in the mitochondrion (25). The pathway is initiated by the 
homocitrate synthase (HCS)-catalyzed condensation of AcCoA and α-ketoglutarate to 
give the enzyme-bound intermediate homocitryl-CoA, which is hydrolyzed by the 
same enzyme to give homocitrate. Homocitrate synthase catalyzes the first and 
committed step in the pathway, is highly regulated to economize the use of resources 
and its reaction is believed to be the rate-limiting step in the pathway. 
Homoaconitase (HAc), an enzyme containing an FeS cluster, catalyzes the 
interconversion of homocitrate and homoisocitrate via the intermediate homoaconitate. 
The enzyme is a member of the aconitase superfamily, which includes 
isopropylmalate isomerase (a member of the leucine biosynthetic pathway in bacteria 
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 and fungi) and aconitases. This is the first documented evolutionary link between the 
α-aminoadipate pathway in fungi and non-fungal organisms (26). 
The resulting homoisocitrate is then oxidatively decarboxylated by the pyridine-
nucleotide linked homoisocitrate dehydrogenase (HIDH) to give α-ketoadipate. This 
enzyme belongs to the pyridine nucleotide-linked β–hydroxyacid oxidative 
decarboxylase family, which is a well-studied class of enzymes (27). 
α–Aminoadipate is then formed via a PLP-dependent aminotransferase (AAT) 
using L-glutamate as the amino donor. Although the first half of the pathway takes 
place in the mitochondrion, the aminotransferase is thought to be present in both 
mitochondrion and cytoplasm. The aminotransferase reaction is also a branch point to 
secondary metabolism including the de novo synthesis of β–lactam antibiotics. In 
addition, the product α–aminoadipate can serve as the sole nitrogen source for 
Filobasidiella neoformans, S. pombe, C. albicans, and A. fumigatus (28). 
In the cytoplasm, the α-aminoadipate reductase (AAR) then reduces α-
aminoadipate to 2-aminoadipate-6-semialdehyde (AAS) via an adenosylated 
derivative, a unique process involving both adenylation and reduction that is found 
only in fungi. However, this enzyme has to be activated by a phosphopantetheinyl 
transferase (PPT). This unique two component system represents a novel reaction in 
fungal amino acid metabolism. In addition, phylogenetic studies and BLAST results 
show that the α-aminoadipate reductase in fungal lysine synthesis is evolutionarily 
related to some bacterial antibiotic peptide synthetases (29). The reductase-catalyzed 
reaction is believed to be the key to evolution of fungal lysine synthesis (29). 
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 Once the semialdehyde is formed, it is condensed with α-ketoglutarate, and the 
imine is reduced by NAD(P)H to L-saccharopine catalyzed by saccharopine reductase 
(SR). Finally, saccharopine dehydrogenase (SDH) catalyzes the oxidative deamination 
of saccharopine to give L-lysine. It is of interest that saccharopine is a stable 
intermediate and pyridine nucleotides, rather than a vitamin B6 – dependent 
transamination of the semialdehyde is used by fungi. The last two enzymes have very 
little sequence homology at the amino acid level, but both enzymes are fungi specific 
and catalyze very similar reactions. Since NADPH and NADH are used as coenzymes 
by these two enzymes respectively, a high NADPH to NADH ratio may favor the 
synthesis of lysine from aminoadipate semialdehyde, whereas a low ratio would 
discourage such synthesis and favor the reverse reactions. 
The pathway occurs in two compartments. One of the reasons may be due to the 
availability of NAD(P)H and ATP, of allosteric regulators, or the proper environment 
to give the active site residues of the enzymes an optimum protonation state in order to 
catalyze the reactions involved along the pathway. The split between two 
compartments may also contribute to a better overall regulation of the whole pathway, 
or a secondary metabolic pathway. 
It has been reported that an α-aminoadipate-like pathway is present in Thermus 
thermophilus and Pyrococcus horikoshii (30-31). However, this pathway is not the 
same as that found in fungi. The first half of the pathway is similar to that presented 
above, but α-aminoadipate is first converted to N-acetyl-α-aminoadipate, which is 
phosphorylated at the ε–carboxylate, and then reductively dephosphorylated to the ε–
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 aldehyde. The aldehyde is then transaminated to N-acetyl-L-lysine, which is 
deacetylated to give L-lysine (18, 29). 
 
1-2-3. Significance of the α-aminoadipate pathway 
A number of fungal alkaloids or peptides have lysine as a structural element or 
biosynthetic precursor. In addition, several α-aminoadipate pathway intermediates are 
incorporated into secondary metabolites. The best example is α-aminoadipate as an 
essential precursor for penicillins in the synthesis of ACV (L-δ-(α-aminoadipoyl)-L-
cysteinyl-D-valine) tripeptide (32). 
The uniqueness of the α-aminoadipate pathway makes it a target for the rapid 
detection and control of pathogenic yeasts and molds. Selective inhibition of the 
enzyme(s) of this pathway by (an) appropriate substrate analog(s) may control or 
eradicate the growth of fungal pathogens in vivo (9, 14). To date, however, there are 
only a few novel compounds designed to target early steps in the pathway, specifically 
those steps involving the synthesis of (R)-homocitrate and (2R, 3S)-homoisocitrate 
(33).  
 
1-2-4. Regulation of the α-aminoadipate pathway 
The α-aminoadipate pathway for the biosynthesis of lysine is highly regulated at 
the level of both enzyme synthesis and activity (4). 
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 1-2-4-1. Genetic regulation 
The pathway is regulated by the general mechanism for the control of amino acid 
biosynthesis as well as a pathway-specific coinducer-dependent transcriptional 
activation (25, 34-36). The coinducer is α-aminoadipate semialdehyde (AAS), which 
is an intermediate of the pathway (34). In S. cerevisiae, expression of the lysine genes 
can be stimulated by Lys14p in the presence of its coinducer AAS (34). Production of 
the coinducer is also under the control of the metabolic flux mediated by feedback 
inhibition by lysine of the first enzyme in the pathway, homocitrate synthase (37-38). 
Thus, lysine can repress the expression of its biosynthetic genes. Excess lysine also 
acts as a repressor of six of the enzymes of the pathway (25, 39). Lysine inhibits its 
own biosynthesis by feedback inhibition of HCS, which decreases the concentration of 
AAS, and eliminates induction by Lys14p. Several mutants were identified that were 
insensitive to lysine inhibition (40), and the loss of sensitivity was shown to result 
from mutagenesis of the HCS gene (LYS20 or LYS21). A 4- to 10- fold increase in 
lysine production was observed upon transformation of the mutant genes. These 
results support the role of HCS in the repression of the lysine biosynthetic enzymes. 
Two unlinked genes, LYS9 (saccharopine reductase) and LYS14 (transcriptional 
activator) are required for the production of saccharopine in S. cerevisiae (23). Strains 
mutated in these genes accumulate AAS and show a significant reduction in 
saccharopine reductase activity. Mutation of LYS9 results in lysine auxotrophy and no 
reductase activity. Mutation of LYS14 causes yeast to grow slowly in the absence of 
lysine with a low level of reductase activity. Lys14p is required for the expression of 
9
 the LYS9 gene and it has a regulatory role with AAS as the coinducer of transcriptional 
activation. Therefore, a low level of reductase activity in the LYS14 mutants is because 
of the weak expression of the LYS9 gene in the absence of the semialdehyde 
coinduction (2, 34). 
Lys14p is a 90 kDa (790 amino acids) protein that participates in a complicated 
network of protein-protein interactions with 65 other proteins (Biomolecular 
Interaction Network Database, available at www.bind.ca). Lys14p contains a DNA 
binding domain similar to the Zn2Cys6 binuclear cluster of other fungal transcriptional 
activators like Gal4p and Ppr1p (41-42). Promoters of genes responding to this type of 
transcriptional activator usually contain an upstream activating sequence (UAS) that, 
in most instances, consists of two CGG triplets that are separated by a specific number 
of bases dependent on the specific activator. In the case of Gal4p and Ppr1p, the 
intervening sequence consists of 11 and 6 base pairs, respectively. These proteins bind 
as a dimer to the target sequence (UAS) with each of the zinc clusters binding to a 
CGG triplet (43-44). 
Using a deletion and insertion approach, a UAS responsible for binding Lys14p 
has been identified in the promoter regions of the LYS1 (saccharopine dehydrogenase) 
and LYS9 genes from S. cerevisiae which differs slightly from the above-mentioned 
consensus sequence (36). The UAS for the transcriptional activation of the LYS1 and 
LYS9 genes consists of a TCC and GGA triplet separated by 3 base pairs. One or 
several copies of this nine bp sequence has been found in the promoter of at least four 
other LYS genes, including LYS20 (cytosolic homocitrate synthase), LYS21 
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 (mitochondrial homocitrate synthase), LYS2 (α-aminoadipate reductase), and LYS4 
(homoaconitase). LYS5 (phosphopantetheinyl transferase), which does not respond to 
the Lys14p transcriptional activation, does not contain the UAS element (36). 
In S. cerevisiae one cannot exclude the possibility that some other enzyme-
catalyzed step(s) may be rate-limiting step(s) and acts in a manner similar to HCS in 
the regulation of lysine synthesis. For example, in P. chrysogenum, overexpression of 
HCS does not lead to an increase in α-aminoadipate even in a strain in which the LYS2 
gene, which encodes α-aminoadipate reductase, is disrupted. These results suggest the 
presence of at least one additional rate-limiting step between the HCS and the α-
aminoadipate reductase catalyzed reactions (46). 
 
1-2-4-2. Regulation of enzyme activity 
The activity of HCS is highly regulated. It can be feedback inhibited by lysine, the 
end-product of the pathway. The Ki for lysine inhibition of HCS in T. thermophilus 
and P. chrysogenum is only around 9 µM (13, 47). In P. chrysogenum, the synthesis of 
penicillin is regulated by lysine through the inhibition of homocitrate synthase (48-
49), which results in a decrease in the concentration of α-aminoadipic acid, the branch 
point for the biosynthesis of penicillin and lysine. The effect of lysine can be reversed 
by addition of aminoadipic acid and other intermediates of the pathway such as α-
ketoadipate and homocitrate (48-49). The inhibition by lysine is partial in P. 
chrysogenum (13). Luengo et al. (50) suggest the partial inhibition is essential for 
maintaining a steady state level of α-aminoadipate for penicillin production. 
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 It has also been found that the inhibition of HCS by lysine is pH dependent in P. 
chrysogenum (13). Inhibition could not be detected at pH 6.6 to 7.0 with 0.5 mM 
lysine, while a Ki of 8 µM for lysine was measured at pH 8.0. In P. chrysogenum, the 
cytosolic pH is controlled by a proton gradient, generated by a cytoplasmic membrane 
ATPase. A decrease in the ATP concentration will result in a decreased cytosolic pH 
and an increase in HCS activity, allowing the fungus to use intermediates from the 
lysine biosynthetic pathway to produce secondary metabolites. 
Kohlhaw et al. (51-54) reported that CoA, the product of the HCS reaction, can 
inactivate the enzyme from S. cerevisiae and this could be prevented by lysine and α-
ketoglutarate. The inactive enzyme could not be reactivated by addition of AcCoA 
(51). A similar inactivation was also observed for α-isopropylmalate synthase and β-
hydroxy-β-methylglutaryl-CoA reductase, both of which also use AcCoA as a 
substrate (55-56). 
 
1-3. Enzymes of the α-aminoadipate pathway 
1-3-1. Enzyme-catalyzed Claisen condensation of AcCoA and α-keto acids 
A Claisen condensation is a base-catalyzed condensation of a carbon α to an ester 
carbonyl and another carbonyl containing compound, e.g., a ketone or aldehyde (57). 
An example is shown in Fig. 1-3, where the nucleophilic carbon is generated by 
enolization of the ester, catalyzed by a general acid or base. The carbanion then adds 
to the electrophilic carbonyl carbon of the ketone to generate the β-hydroxy ester. 
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Fig. 1-3: General reaction for a Claisen condensation 
 
The reaction is reversible but the product can be trapped by ester hydrolysis. The 
enzyme-catalyzed Claisen reactions catalyzed by the following enzymes are between a 
carbon α to a thioester (AcCoA) and a α-keto acid: homocitrate synthase, α-
isopropylmalate synthase, methylthioalkylmalate synthase, citramalate synthase, 
citrate synthase and malate synthase. These enzymes are bifunctional in that they 
catalyze the reversible formation of the β-hydroxy ester and the subsequent hydrolysis 
of the thioester. 
Citrate synthase is the most thoroughly studied of the enzymes that catalyze this 
type of reaction. The enzyme is a dimeric protein that does not require a divalent 
cation for catalysis. There are thought to be three different steps in the overall reaction 
catalyzed by this class of enzyme: enolization of the thioester to generate the α-
carbanion, condensation to form the acyl-CoA, and hydrolysis of the acyl-CoA. In the 
citrate synthase reaction, enolization of AcCoA is thought to be the rate-limiting step 
(58-61). 
In the citrate synthase reaction, OAA binds to enzyme first and His320 forms a 
hydrogen bond to its keto-oxygen, making it more electrophilic and susceptible to the 
nucleophilic attack by the methyl of AcCoA. AcCoA then binds to the enzyme-OAA 
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 complex, with its methyl near Asp375 and its thioester hydrogen-bonded to His274. 
Enolization of AcCoA then occurs with His274 protonating the thioester oxygen and 
Asp375 accepting a proton from the methyl. C2 of the enolate then attacks the 
carbonyl carbon of OAA, and His320 donates a proton resulting in the intermediate 
citryl-CoA. Formation of the intermediate results in inversion of configuration of the 
protons of the attacking methyl group. At this point the reaction is reversible. With the 
help of the general acid Asp375, citryl-CoA is then hydrolyzed to yield citrate and 
CoA. 
Malate synthase catalyzes the condensation of glyoxylate and AcCoA to form 
malate and CoA. It differs from citrate synthase in its overall structure, but uses a 
similar catalytic strategy for its reaction. Opposed to citrate synthase, malate synthase 
is a Mg-containing metalloenzyme. The Mg2+ ion takes the place of the imidazole that 
hydrogen-bonds the carbonyl of OAA in the citrate synthase reaction and also 
functions in positioning the glyoxylate in a suitable orientation for reaction. In the 
formation of the enolate intermediate of AcCoA, an Asp residue acts as the general 
base and an Arg residue is thought to stabilize the enolate intermediate. Thus, although 
the overall reaction is the same as that catalyzed by citrate synthase, the mechanism is 
quite different (62-64). α-Isopropylmalate synthase, which catalyzes the reaction 
between α-ketoisovalerate and AcCoA, is a Zn-metalloenzyme, with the Zn2+ thought 
to participate in a role similar to Mg2+ in the malate synthase reaction (65). Although 
the reactions catalyzed by this class of enzyme are similar, their mechanisms differ. 
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 1-3-2. Homocitrate synthase 
1-3-2-1. Location of HCS 
Using cell fractionation techniques, Tracy et al. (51) proposed that most of the 
HCS activity in S. cerevisiae was located in mitochondria (80%) with the remainder in 
cytosol. Ramos et al. (37) suggested 70% of HCS activity is cytosolic, due to Lys20p 
and the remainder, resulting from Lys21p was located in mitochondria. Using 
monoclonal antibodies and immunofluorescence, Chen et al. (66) showed that both 
isoenzymes are also located in the nucleus. Results were subsequently corroborated 
using HCS-GFP fusion proteins (40). Upon deletion of the two HCS genes, no 
phenotype was found other than lysine auxotrophy. Neither isoenzyme has a signal 
sequence for targeting to mitochondria, or a canonical sequence for nuclear 
localization. These interesting findings raise questions concerning why HCS is located 
in nucleus. The localization of HCS in P. chrysogenum has also been studied recently 
(67). Using HCS-GFP fusion protein, HCS was localized in the cytoplasm and 
mitochondria with the majority in the cytoplasm; the same result was obtained by cell 
fractionation techniques (13). 
 
1-3-2-2. Expression, purification, and characterization 
In 1995, Verhasselt et al. (68) reported that the sequence of open reading frame 
D1298 (YDL 182w) in chromosome IV of S. cerevisiae had a significant sequence 
similarity with the NifV gene from Azotobacter vinelandii which encodes HCS. 
Homocitrate is a component of the FeMo cofactor which is contained in nitrogenase 
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 for nitrogen fixation in A. vinelandii (69-70). Disruption of this gene in S. cerevisiae 
gave a three-fold decrease in HCS activity (37). A 10-fold increase in HCS activity 
was observed when a strain was transformed with a plasmid containing the putative 
HCS genes, given the name LYS20. The LYS20 gene product accounts for almost 70% 
of lysine synthesis, and is subject to repression by lysine. Disruption of the LYS20 
gene did not inhibit cell growth on minimal medium and significant HCS activity was 
still measurable, suggesting there are at least two HCS isoenzymes in S. cerevisiae. 
As early as 1972, two isoenzymes of homocitrate synthase were identified in S. 
cerevisiae, both of which could be inhibited by lysine (38). Using monoclonal 
antibodies, Chen et al. showed that two isoenzymes of HCS, 47,000 Da and 49,000 
Da, respectively, are located in the nucleus (66), and the 47,000 Da HCS corresponded 
to Lys20p. The 49,000 Da HCS was the product of a separate gene named LYS21. The 
gene and protein sequences of the two enzymes shared 90% identity, and are located 
on Chromosome IV in S. cerevisiae, suggesting they originated from gene duplication. 
Deletion of the LYS20 and LYS21 genes in S. cerevisiae, resulted in the elimination of 
HCS activity. 
In order to obtain 50% inhibition of HCS activity, 1 mM and 0.15 mM lysine are 
required for Lys20p and Lys21p, respectively (40). This explains why Lys20p 
accounts for most of the lysine synthesized. The sensitivity of Lys21p to lysine is such 
that it is predominantly inactive, and may only be active under conditions of extreme 
lysine deficiency. 
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 The subunit composition of HCS has been studied in several organisms. The HCS 
in A. vinelandii is a dimer, while that from T. thermophilus is thought to be a 
monomer, and that from P. chrysogenum is reported to have multiple subunits (13, 47, 
70). It appears the organization of HCS in bacteria is simpler than that in fungi. This is 
consistent with the more complex allosteric regulation of HCS in fungi (47). 
Homocitrate synthase is not stable as isolated. Crude HCS from 
Saccharomycopsis lipolytica is stable for a week at 4 °C (71), but 50% of the HCS 
activity from A. vinelandii was lost within 2 hr when exposed to air (70). The enzyme 
from P. chrysogenum loses 65% of its activity upon storage at 4-6 °C for 48 hrs, even 
in the presence of 20% glycerol (13). 
 
1-3-2-3. Kinetic mechanism 
An ordered kinetic mechanism has been proposed for the HCS from S. lipolytica 
with α-ketoglutarate binding before AcCoA (71). The authors reported a sigmoid 
saturation curve for AcCoA. A sigmoid saturation curve for AcCoA was also reported 
for the enzyme from P. chrysogenum (13). It has been also demonstrated that the HCS 
from T. thermophilus is capable of catalyzing the reaction using oxaloacetate in place 
of α-ketoglutarate as a substrate, and thus behaves as a citrate synthase (47). Virtually 
nothing is known of the chemical mechanism of the HCS and the structure is currently 
not available. 
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 1-3-3. Homoaconitase 
Homoaconitase (E.C. 4.2.1.36) also known as homoaconitate hydratase, encoded 
by the LYS4 gene in S. cerevisiae, catalyzes the interconversion of homocitrate and 
homoisocitrate via the intermediacy of cis-homoaconitate. The enzyme is a member of 
the aconitase superfamily. It is a mitochondrial enzyme that is repressed by both lysine 
and glucose. The enzyme from Aspergillus nidulans is 55% sequence identical to that 
from S. cerevisiae, with the greatest similarity in the region attributed to binding of an 
FeS cluster (2). However, little is known of the mechanism of the homoaconitase, but 
its mechanism may be similar to that of aconitase (72). 
 
1-3-4. Homoisocitrate dehydrogenase  
Homoisocitrate dehydrogenase (3-carboxy-2-hydroxyadipate dehydrogenase; E.C. 
1.1.1.87) catalyzes the NAD+-dependent conversion of homoisocitrate to α-
ketoadipate. Other than its sequence, almost nothing is known about the mechanism of 
this enzyme. Based on the general mechanism of the pyridine nucleotide-linked β–
hydroxyacid oxidative decarboxylases (27), the mechanism may be similar to that of 
isocitrate dehydrogenase (73). Whether the enzyme requires a divalent metal ion to 
catalyze its reaction as does isocitrate dehydrogenase will have to be determined. 
 
1-3-5. α-Aminoadipate aminotransferase  
α-Aminoadipate aminotransferase (E.C.2.6.1.39) is a PLP-dependent enzyme 
responsible for the conversion of α–ketoadipate to α–aminoadipate using L-glutamate 
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 as the amino donor, and generating α–ketoglutarate as the second product. The 
aminotransferase reaction is also a branch point to secondary metabolism including the 
de novo synthesis of β–lactam antibiotics. 
In S. cerevisiae, two isozymes of the aminotransferase have been isolated (2, 74-
75). Isozyme I is localized in the mitochondrion, is inhibited by α–ketoglutarate, and 
utilizes either L-glutamate or L-aspartate as the amino donor, but exhibits only weak 
activity with α–aminoadipate as the amino donor. Isozyme II is localized in the 
cytosol, has a strict requirement for L-glutamate as the amino donor, and is not 
inhibited by α–ketoglutarate. Neither isoform is inhibited by lysine, but the activity of 
isozyme II is repressed by α–aminoadipate and slightly repressed by glucose. Only the 
cytosolic isoform appears to be specific for the α–aminoadipate pathway. Its 
mechanism is expected to be ping pong on the basis of ample precedence from other 
aminotransferases, but its specific mechanism will have to await future studies. 
 
1-3-6. α-Aminoadipate reductase 
α-Aminoadipate reductase (E.C.1.2.1.31), also known as α–aminoadipate 
semialdehyde dehydrogenase catalyzes the reduction of α-aminoadipate to α–
aminoadipate δ-semialdehyde in the cytoplasm, a unique reaction involving both 
adenylation and reduction. On the basis of early investigations (76-77), the AAR-
catalyzed reaction is believed to be a three-step process, with the amino acid first 
reacting with ATP to form an adenylyl derivative, followed by the reduction of the 
adenylyl derivative of α-aminoadipate by NADPH, followed by cleavage of the 
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 reduced adenylyl derivative of the amino acid to form α-aminoadipate-δ-
semialdehyde. The first and second steps require MgATP and NADPH, respectively, 
while the third step requires no cofactors. The product of the first step was 
successfully isolated and identified as an δ-5′-adenylyl-L-α-aminoadipate by 
Bhattacharjee’s group, while the product of the second step was too unstable to be 
identified (78). Formation of the δ-5′-adenylyl-L-α-aminoadipate, rather than 
phosphorylation of the substrate by ATP makes this reaction a unique process. 
The enzymatic conversion of α–aminoadipate to the δ-semialdehyde requires 
expression of two genes in S. cerevisiae, LYS2 and LYS5. The reductase, encoded by 
LYS2, contains domains for ATP hydrolysis, thioester formation with a 4-
phosphopantetheine binding consensus sequence and an active site serine residue. The 
reductase is feedback inhibited by lysine and thialysine (2, 79). The active form of the 
reductase requires an additional activity catalyzed by Lys5p, a member of the 
phosphopantetheinyl transferase (PPTase) family (80). It has recently been shown that 
Lys5p is a posttranslational modification catalyst, which uses coenzyme A (CoASH) 
as a cosubstrate to phosphopantetheinylate Ser880 of AAR, activating it for catalysis 
(81). Thus, the phosphopantetheinyl transferase and the α–aminoadipate reductase 
(Lys2p/Lys5p heterodimer) represent a two component system with the transferase 
covalently priming the reductase, a novel mechanism for fungal amino acid 
metabolizing enzymes. A human homolog of the α–aminoadipate reductase-
phosphopantetheinyl transferase gene has been identified (82). The posttranslational 
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 activation of the LYS2 encoded α-aminoadipate reductase from C. albicans has also 
been investigated (83). 
A mechanism for the reductase from S. cerevisiae has been proposed by Walsh’s 
group (81). The reductase is first activated by phosphopantetheinylation using the 
transferase. The activated reductase then catalyzes the adenylation of the δ-
carboxylate of α–aminoadipate via the adenylation (A) domain, followed by acyl 
transfer of the aminoadipoyl moiety to the thiol of the phosphopantetheine to generate 
the thioester of the phosphopantetheinyl cleavage protein (PCP) domain. Hydrolysis of 
the MgPPi product of the adenylation reaction is used to drive the reaction toward the 
adenylated intermediate. The covalent thioester intermediate is reduced by NADPH to 
regenerate reduced phosphopantetheine and the final semialdehyde product. The latter 
reaction is similar to the reverse of glyceraldehyde 3-phosphate dehydrogenase 
reaction. Each of the partial reactions of the overall reaction can be studied 
independently, but mechanistic details will have to await future studies. 
The S. cerevisiae α–aminoadipate reductase is evolutionarily related to some of 
the bacterial antibiotic peptide synthetases (30). Multienzyme complexes also exist for 
adenylation and partner-protein-specific posttranslational activation of non-ribosomal 
peptide synthetases (NRPS) in the synthesis of antibiotics, e.g. bacitracin, 
cyclosporine, penicillin, and vancomycin (80). However, the yeast AAR has two 
unusual features as a non-ribosomal peptide synthetase type catalyst, an unusual 
organization with a reductase domain fused down-stream of the prototypic 
adenylation/peptidyl carrier protein domains, and an unusual regiospecific activation 
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 of its amino acid substrate (81). Nonetheless, the homology of adenylation and 
posttranslational modification of AAR to those of NRPS suggests the reductase-
catalyzed reaction is the key to the evolution of fungal lysine synthesis. The link 
between AAR and NRPS may be useful for the design of antifungal agents since 
Lys2p and Lys5p are essential for fungal growth. 
 
1-3-7. Saccharopine reductase 
Saccharopine reductase (SR) (E.C. 1.5.1.10), also known as aminoadipate 
semialdehyde-glutamate reductase or saccharopine dehydrogenase (N6-(L-1, 3-
dicarboxypropyl)-L-lysine: NADP+ oxidoreductase (L-glutamate-forming)), is the 
penultimate enzyme of the α-aminoadipate pathway for lysine biosynthesis (3, 12, 87). 
The enzyme catalyzes the synthesis of saccharopine via the reversible condensation of 
α-aminoadipate-δ-semialdehyde with L-glutamate using NADPH as the reducing 
agent. 
 
1-3-7-1. Expression, purification, and characterization 
The enzyme from S. cerevisiae has a monomer M.W. of 50,000 by SDS-PAGE 
and is stable for several weeks when stored at -70 °C in Tris, pH 8.0 containing 1 mM 
PMSF, 10 mM 2-mercaptoethanol and 5 mM EDTA (88). A molecular weight of 
67,000 was reported from gel filtration chromatography (88), close to a value of 
73,000 estimated from sucrose density gradient centrifugation (89). The difference 
between M. W. obtained under native and denaturing conditions was attributed to an 
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 unusual protein conformation (88). Additional studies gave a M.W. of 70,000-90,000 
under native conditions suggesting a dimeric structure in solution for the fungal 
enzymes (4). A M.W. of 84,000 was obtained by gel-filtration chromatography for the 
enzyme from Magnaporthe grisea suggesting a dimeric structure in agreement with 
structural studies (84, 90). 
pH optima of 7.0 for the saccharopine formation reaction (88), and 9.5-9.75 for 
the α-aminoadipate-δ-semialdehyde formation reaction were reported for the enzyme 
from S. cerevisiae (88-89). The enzyme is unstable above 34 °C (88). Estimates of Km 
values for L-saccharopine, NADP+ and NAD+ were estimated at 2.3 mM, 0.022 mM 
and 0.054 mM, respectively (88-89). It has been reported that NADPH is far more 
effective than NADH in the forward reaction (12, 89). Because α-aminoadipate-δ-
semialdehyde is not readily available, the enzyme is typically assayed in the reverse 
reaction direction (2). 
Carbonyl reagents such as hydroxylamine, isoniazid and semicarbazide have no 
effect on enzyme activity, but some metal chelators such as 2, 2-bipyridine and 1, 10-
phenanthroline inhibit the enzyme (88). The enzyme may require a sulfhydryl group 
for activity as suggested by complete inhibition in the presence of mercuric chloride 
(88) or p-hydroxymercuribenzoate (12, 88). The inactivation is attributed to 
modification of Cys155 in the S. cerevisiae enzyme, which is in the proximity of the 
saccharopine binding site, but not positioned to participate in the reaction (84). 
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 1-3-7-2. Structure 
The crystal structure of the saccharopine reductase from M. grisea has been 
solved (84, 90). M. grisea is a pathogenic fungus of grass species and it is responsible 
for enormous losses in the rice crop annually (84, 91). The purified saccharopine 
reductase from M. grisea was crystallized, and structure of the apo enzyme and ternary 
E:NADPH:saccharopine complex were solved to 2.0 Å and 2.1 Å, respectively. The 
apo enzyme and ternary complex structures were homodimeric with each subunit 
binding one NADPH and one saccharopine molecule (84). A ribbon diagram of the 
apo structure of SR is shown in Fig. 1-4A. 
The polypeptide chain of the saccharopine reductase from both M. grisea folds 
into three domains. The first domain is a variant of the dinucleotide-binding Rossmann 
fold (92) that binds to NADP+ or NADPH. The second domain is an α/β fold known as 
the saccharopine reductase fold. This domain consists of a central seven-stranded 
 
A B
Fig. 1-4: Three dimensional structure of saccharopine reductase from Magnaporthe grisea (84).
A. Ribbon diagram of the dimer. Color depiction is based on the dimer symmetry. PDB accession 
number is 1E5L. B. Close up view of the active site of the saccharopine reductase from M. grisea
with NADPH and saccharopine bound. PDB accession number is 1E5Q. Figures produced using 
PyMOL (www.pymol.org). 
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 mixed β-sheet. The third domain is an all-helical domain that moves upon binding of 
substrates. The active site is in a deep cleft that forms between domains one and two 
(84). 
One common interacting surface exists between the monomeric units in all 
structures solved, and it was thus identified as the dimer interface. The two subunits in 
the homodimer are related by two-fold symmetry. The dimer interface contains 45% 
polar and 55% nonpolar residues. The majority of the residues at the subunit interface 
of the fungal enzymes are conserved, while they vary for enzymes from plants and 
mammals, suggesting there may be a different type of subunit interaction for the 
fungal organisms (84). 
Binding of the ligands to the saccharopine reductase from M. grisea induces a 
conformational change that includes a rotation of domain three by 17.7° and a 
translation of -0.93 Å compared to the structure of the apo enzyme, making the active 
site less accessible to solvent. NADPH binds in an extended conformation to the 
Rossmann fold that contains a β-α-β motif with a conserved sequence of GXGXXG 
(where X is any amino acid). The nicotinamide ring is deeply buried in the cleft and is 
not accessible to solvent. The carboxamide side chain of NAD(P)H is anchored to the 
protein by several main chain hydrogen bonds that determine the orientation of the 
ring and the pro-R (A-side) stereospecificity of hydride transfer. Saccharopine is held 
by a combination of hydrogen bonds, salt-bridges and hydrophobic interactions to the 
protein, Fig. 1-4B (84). 
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 1-3-7-3. Chemical mechanism 
A chemical mechanism can be written using the general mechanism for amino 
acid dehydrogenases and is shown in Fig. 1-5, path A. An imine is formed by attack of 
the α-amine of glutamate on the δ-aldehyde of α-aminoadipate semialdehyde, likely 
facilitated by a general acid-base catalyst. Based on the three-dimensional structure of 
the ternary complex, the general acid-base catalyst is likely Asp126, since there are no 
other residues in the vicinity of saccharopine that could facilitate proton transfer. 
Reduction of the imine then gives the product saccharopine. A second possibility 
involves the cyclic imine formed by attack of the α-amine of AAS on its δ-aldehyde, 
Fig. 1-5, path B. In this case, the α-amine of glutamate attacks the imine carbon in a 
transimination reaction, generating the same imine intermediate (in the dashed box) as 
shown in path A. Similar acid-base chemistry is used, but the physical rearrangement 
to generate the common imine may not be accommodated in the saccharopine 
reductase active site. The conformation of saccharopine as bound in the 
E:NADPH:saccharopine structure favors path A (84). In addition, the principle of 
microscopic reversibility requires the imine be formed as the product in the reverse 
reaction, which is unlikely. Nevertheless, this mechanism cannot be ruled out at 
present. 
The structure of the saccharopine reductase shows a high structural similarity to 
enzymes of the diaminopimelate pathway (members of the aspartate family of amino 
acid biosynthetic pathways), despite the lack of overall amino acid sequence 
homology. In general, the structure of domain 1 (Rossmann fold) is highly conserved, 
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 while the domains 2 and 3 structures are less conserved. Since the AAA and DAP 
pathways belong to two different amino acid biosynthetic families, the structural 
similarity may suggest an evolutionary relationship between these two pathways, with 
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 some of the enzymes evolving from a common ancestor (84). However, the 
evolutionary history of this unique fungal lysine pathway is not well established. 
 
1-3-8. Saccharopine dehydrogenase 
Saccharopine dehydrogenase (N6-(glutaryl-2)-L-lysine: NAD+ oxidoreductase (L-
lysine forming); (EC 1.5.1.7)) is the last enzyme in the α-aminoadipate pathway for 
lysine biosynthesis. It catalyzes the reversible pyridine nucleotide-dependent oxidative 
deamination of saccharopine to generate α-ketoglutarate and lysine using NAD+ as an 
oxidizing agent. 
 
1-3-8-1. Expression, purification, and characterization 
A monomeric subunit structure was reported for the enzyme from S. cerevisiae 
with a molecular weight of 39,000 Da (93). It is a basic protein with a pI of 10.1, and 
is stable for months at -20 °C at concentrations ≥ 0.1 mg/ml and a pH of 5-8 (93). It 
contains 4 cysteine residues but no disulfide bonds, and one binding site for reactants 
per molecule of enzyme (94). The LYS1 gene has been cloned from C. albicans (14) 
and S. pombe (95). 
 
1-3-8-2. Kinetic mechanism 
The overall reaction catalyzed by SDH is reversible. The S. cerevisiae enzyme has 
an optimum pH in the direction of lysine formation of 10, while in the direction of 
saccharopine formation it is 7 (2, 96). The Km values for NAD+, saccharopine, lysine, 
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 α-ketoglutarate, and NADH were estimated as 0.1 mM, 1.7 mM, 2 mM, 0.55 mM, and 
0.089 mM, respectively (2). SDH from S. cerevisiae shows very strict substrate 
specificity with respect to its amino acid and keto acid substrates (97-98). Only 
pyruvate has been observed as an alternative substrate in the direction of ε–N-(L-
propionyl-2)-L-lysine formation (99). In addition, the enzyme exhibits a high degree 
of coenzyme specificity (97, 100). It does utilize NADPH as a poor substrate, but with 
a much lower affinity compared to NADH (96). Furthermore, binding of NADPH 
causes an increase in the Km values for α-ketoglutarate and lysine (96). Coenzyme 
fragments, such as AMP, ADP, ADP-Ribose, and ATP, inhibit the enzyme activity, 
but no inhibition is observed by adenine, 3′-AMP, 2′-deoxy-5′-AMP, IMP, GMP, 
pyrimidine nucleotides, NMN+, and NMNH (96). Data suggest that the AMP moiety 
of NAD+ is responsible for majority of the binding energy. The lack of inhibitory 
effect of 2′-deoxy-5′-AMP and low affinities of NADPH suggests that the interaction 
of the oxygen at the 2′ position of the adenosine moiety with the enzyme is important 
in binding (96). No binding of lysine or α-ketoglutarate to free enzyme was detected. 
A number of pyridine nucleotide dehydrogenases that have an ordered kinetic 
mechanism exhibit substrate inhibition. SDH was reported to exhibit inhibition by 
high concentrations of α-ketoglutarate and lysine in the direction of saccharopine 
formation, but not by saccharopine in the oxidative direction (101). 
Hydrophobic amino acids with 5 and 6 carbon atoms, leucine, norleucine, and 
norvaline, were potent inhibitors, while branched-chain isomers, valine, isoleucine, 
and α-aminobutyrate inhibited weakly, and no inhibition was observed by aspartate, 
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 glutamate, or α-aminoadipate (98). It appears that a hydrophobic interaction between 
the side chain of an amino acid and the enzyme is important in binding the amino acid 
reactant. Inhibition observed with keto acid analogues was more complicated. 
Noncompetitive inhibition was observed with oxalacetate, pyruvate, α-ketobutyrate, α-
ketovalerate, and α–ketocaproate whether NADH, α-ketoglutarate, or lysine was the 
varied substrate, inconsistent with the proposed kinetic mechanism. Data suggested 
combination of the dead-end inhibitors with more than one enzyme form, but this 
aspect will have to await future studies (98). 
An ordered Bi-Ter kinetic mechanism was proposed for the SDH with NAD+ 
binding first, followed by saccharopine, and products released in the order of lysine, α-
ketoglutarate, and NADH (2, 98, 102). Since all substrates must add to the enzyme 
before any product is released, the enzyme may be considered to have separate 
binding sites for the coenzyme, keto and amino substrates. With pyruvate as a 
substrate, data also suggest an ordered ter-reactant mechanism in the direction of ε–N-
(L-propionyl-2)-L-lysine formation, but with the order NAD+, ε–N-(L-propionyl-2)-L-
lysine, pyruvate, lysine, and NADH (103). The reversal in the release of lysine and the 
keto acid suggests that there may be randomness in substrate binding. 
 
1-3-8-3. Chemical mechanism 
SDH is a pro-R specific for hydride transfer from C2 of the saccharopine glutaryl 
moiety to the nicotinamide ring of NAD+ (85-86). A series of chemical modification 
experiments suggested the presence of essential cysteine (94), histidine (104), lysine 
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 (105), and arginine residues (106) that may be involved in substrate-binding and/or 
catalysis. A chemical mechanism for the enzyme has been proposed on the basis of 
pH-rate profiles and product and dead end inhibition studies, Fig. 1-6 (86). 
Saccharopine is first oxidized to the ε–glutaminyl-L-lysine. A general base then 
activates water for attack to form a carbinolamine intermediate, which collapses to 
give the products, L-lysine and α–ketoglutarate using general acid, general base 
chemistry. 
In the direction of saccharopine formation, the pH dependence of V/Klysine 
exhibits a pK of 6.3 for a group that must be unprotonated, and a pK of 8.0 for a group 
that must be protonated for activity (86). Temperature and solvent perturbation studies 
are consistent with these groups being histidines. The V/Kα-kg pH profile exhibits a 
single pK of 8.4 for a group that must be protonated for α–ketoglutarate binding (86). 
Fig. 1-6: Proposed chemical mechanism for saccharopine dehydrogenase. 
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 In the direction of saccharopine cleavage, the V/Ksacch pH profile shows two pKs of 
6.0 and 7.1 that must both be unprotonated for catalysis and/or binding of 
saccharopine (86). Although the mechanism proposed in Fig. 1-6 is certainly 
consistent with the data, studies are incomplete and the identity of the groups involved 
is based on the observed pK values, their temperature dependence, and chemical 
modification studies; all are notoriously inaccurate. 
 
1-4. Summary 
Although mechanistic precedence for each of the enzyme-catalyzed reactions 
discussed above is available, none of the mechanisms of the enzymes in the first half 
of the α-aminoadipate pathway is known with any certainty. However, some 
information is available for enzymes in the second half of the pathway. A general 
mechanism has been proposed for the α-aminoadipate reductase, but all mechanistic 
detail is lacking. For the saccharopine reductase, only structural information is 
available, with virtually nothing known of its mechanism. Significant, but incomplete, 
mechanistic data have been collected for the saccharopine dehydrogenase, but no 
structural information is available. Regulation of the pathway at the enzyme level is 
not completely clear and little is known about the mechanism of regulation. 
Our understanding of the α-aminoadipate pathway for lysine synthesis at the 
molecular level has been increasing dramatically, together with a growth in genomic 
information. However, a complete understanding of the gene-enzyme relationship, 
mechanisms of the enzymes, regulation of the α-aminoadipate pathway, as well as a 
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 comparative study of the cloned genes would help to gain an understanding of the 
functions of the biosynthetic and catabolic genes and enzymes. Knowledge gained 
using biochemical and molecular techniques with S. cerevisiae can be applied to 
pathogenic fungi to gain a basic understanding of the metabolism of fungal pathogens. 
Systemic fungal infections are among the most difficult infectious diseases to treat and 
are life-threatening for individuals who are immune-suppressed, including those with 
AIDS and other autoimmune diseases, those undergoing chemotherapy, and those who 
have undergone a transplant. All of the presently available antifungal drugs have side 
effects, including nausea, vomiting, and diarrhea, toxicities including hepatotoxicity 
and renal insufficiency, and drug interactions. It is thus important to develop new 
antifungal drugs that are more effective and less toxic. The metabolic pathway for the 
biosynthesis of lysine in fungi is for the most part unique to these organisms, which 
has prompted speculation that the enzymes involved in the pathway may be viable 
targets for selective antifungal agents. Selective inhibition of the enzyme(s) by an 
appropriate substrate analog(s) may control the growth of fungal pathogens in vivo. 
Similarly, the novelty of several genes in the pathway may permit them to serve as a 
molecular marker to facilitate rapid identification of fungal pathogens. 
In this dissertation, extensive kinetic data about homocitrate synthase and the 
crystal structure of the saccharopine reductase from S. cerevisiae is presented. In 
chapter two, we describe for the first time the stabilization of the unstable cytosolic 
HCS using the artificial chaperone-assisted renaturation strategy. The stabilized 
enzyme has also been characterized with respect to its physical properties. In chapter 
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 three, we report the kinetic mechanism of the HCS from S. cerevisiae using initial 
velocity, product and dead-end kinetic studies. In chapter four, we make use of steady 
state kinetic and fluorescence binding studies to probe the kinetics of regulation of the 
cytosolic HCS by Na+ and lysine. In chapter five, a theory is developed for regulation 
by multiple effectors on the basis of studies presented in chapter four. Also, rate 
equations are derived to predict the regulatory effects of Na+ and lysine on the activity 
of HCS, on the basis of experimental data presented in chapter four. The simulated 
data suggest that the activity of the HCS in the presence of Na+ is simultaneously 
inhibited and activated and the Na+ effect is independent of lysine. Finally, in chapter 
six, we report the crystal structure of the apo-histidine-tagged saccharopine reductase 
from S. cerevisiae. A comparative structural analysis with an emphasis on the active 
site is presented. 
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 CHAPTER 2 
Stabilization and characterization of homocitrate synthase 
 
 
“Reproduced with automatic permission from [Andi, B., West A. H., and Cook, P. F. (2004) Stabilization and characterization of 
Histidine-tagged Homocitrate Synthase from Saccharomyces cerevisiae, Arch. Biochem. Biophys. 421, 243-254] Copyright 
[2003] Elsevier Inc.” 
 
2-1. Introduction 
Lysine is the only essential amino acid known to have two distinct anabolic 
pathways for its biosynthesis. The diaminopimelate pathway is found in plants, 
bacteria and lower fungi and begins with the phosphorylation of aspartate by 
α-Ketoglutarate Acetyl-CoA Homocitrate Cis-Homoaconitate Homoisocitrate
α-Ketoadipate α-Aminoadipate α-Aminoadipate semialdehyde Saccharopine L-Lysine
Fig. 2-1: α-Aminoadipate pathway for the synthesis of lysine. Homocitrate synthase catalyses the first
and committed step of the pathway. The enzymes of the pathway are as follows: (1) Homocitrate
synthase, (2) Homoaconitate hydratase, (3) Homoisocitrate dehydrogenase, (4) α-Aminoadipate 
aminotransferase, (5) α-Aminoadipate reductase, (6) Saccharopine dehydrogenase (L-Glu forming), 
(7) Saccharopine dehydrogenase (L-Lys forming). 
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 aspartokinase. Human pathogenic fungi such as Candida albicans, Cryptococcus 
neoformans and Aspergillus fumigatus and plant pathogens like Magnaporthe grisea 
use the α-aminoadipate pathway for the synthesis of the lysine (Fig. 2-1). The human 
pathogens represent a major health threat for patients with cancer, transplant patients 
and AIDS patients undergoing immunosuppressive treatment. In addition, 
Magnaporthe grisea is among the most destructive pathogens in crop plants. The 
uniqueness of the α-aminoadipate pathway makes it a potential target for new 
antifungal drugs (1-6). 
Homocitrate synthase (HCS) [2-hydroxybutane-1,2,4-tricarboxylate 2-
oxoglutarate-lyase (CoA-acetylating), EC 2.3.3.14] catalyzes the first and committed 
step of the pathway (Fig. 2-1) which involves the condensation of α-ketoglutarate with 
acetyl-CoA to yield homocitrate and coenzyme A (1, 7-9). The first half of the α-
aminoadipate pathway has been reported to be located in the mitochondria (10). There 
are two isozymes of homocitrate synthase (cytosolic and mitochondrial) from 
Saccharomyces cerevisiae that are subject to feedback inhibition by lysine. Expression 
of the cytosolic isozyme can be strongly repressed by lysine (7). It has been also 
reported that CoA is capable of regulating the enzyme activity in the presence of 
divalent metal ions (8). 
Homocitrate synthase is an unstable enzyme as isolated. As reported in the case of 
the Penicillium chrysogenum enzyme, storage at 4-6 °C for 48 hrs in the presence of 
20% glycerol results in a 65% loss of activity; after freezing and thawing, 50% of the 
initial activity remained (9). In Saccharomycopsis lipolytica, the enzyme has been 
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 reported to be stable for one week at 4°C (10). In another study, the crude enzyme 
from Saccharomyces cerevisiae was only stable for 4 days at 0 °C (11). 
Using the artificial chaperone-assisted renaturation strategy (12-13), in this paper 
we describe for the first time stabilization of the cytosolic homocitrate synthase from 
Saccharomyces cerevisiae. The stabilized enzyme has been characterized with respect 
to its physical properties. 
 
2-2. Materials and methods 
2-2-1. Chemicals 
All chemicals were of the highest grade commercially available. The Ni-NTA 
agarose resin was from Qiagen, imidazole was from Research Organics, and the rTEV 
protease was from Invitrogen. Acetyl-CoA, α-ketoglutarate, dichlorophenol 
indophenol (DCPIP), CoASH, sucrose, sorbitol, glutamic acid, α-cyclodextrin, PMSF 
and chloramphenicol were obtained from Sigma. (NH4)2SO4, PEG-1500 and 2-methyl-
2,4-pentanediol (MPD) were from Fluka. GdmCl, glycerol and NH4Cl were obtained 
from Fisher Scientific. Hepes and kanamycin were from Amresco. Gdm sulfate was 
purchased from TCI America. Urea, DTT, IPTG and SDS were from Gibco BRL, 
Boehringer Mannheim Biochemicals, Gold BioTechnology, Inc. and Bio-Rad, 
respectively. 
Acetyl-CoA was prepared freshly prior to each assay and the concentration was 
adjusted spectrophotometrically (ε260 nm, 16.4 mM−1cm−1). The average percent 
hydrolysis of the acetyl-CoA preparations as deduced by spectrophotometric 
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 measurements (calculated using the ratio of A260 nm and A232 nm) was about 5% 
(Maximum 10%). The concentration of DCPIP preparations was also adjusted 
spectrophotometrically (ε600 nm, 19.1 mM−1cm−1). 
 
2-2-2. Cell growth and protein expression 
B834 (DE3) RIL/P31-TEV carrying the LYS20 gene (kindly provided to us by Dr. 
F.W. Studier from Brookhaven National Laboratory) was used to express the HCS. 
The RIL plasmid (pACYC-based) confers chloramphenicol resistance and supplies 
extra copies of rare tRNAs. The P31-TEV plasmid is a derivative of pET-28 and 
confers kanamycin resistance. The E.coli strain B834 (DE3) contains a gene for T7 
RNA polymerase and requires methionine for growth. The P31 protein has a 25 amino 
acid insertion at the N-terminal carrying a 6His-tag that is cleavable by rTEV protease. 
The strain was grown in LB medium containing chloramphenicol (25 µg/ml) and 
kanamycin (10 µg/ml) and induction by 0.6 mM IPTG (final concentration) was 
accomplished once an OD600 nm of 0.6-0.8 was reached. Growth was then continued at 
30 °C for 3.5 h. 
After centrifugation, the harvested cells were suspended in 20 mM Hepes, pH 7.5 
containing 300 mM KCl and disrupted using either sonication or French press. After 
removing the cell debris by centrifugation at 12000g for 10 min, the collected 
supernatant was mixed with the Ni-NTA resin at 4 °C, washed with 20 mM imidazole 
and then eluted with buffer containing 200 mM imidazole. 
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 For rTEV protease cleavage, 30 µg HCS was mixed with 10 U rTEV protease in a 
total volume of 100 µl using rTEV buffer (50 mM Tris-HCl, pH 8.0 and 0.5 mM 
EDTA) and the mixture incubated overnight at 4 °C. 
 
2-2-3. Enzyme assay 
A typical assay for the HCS using the DCPIP method contained in a final volume 
of 1 ml; 50 mM Hepes, pH 7.5 (adjusted by KOH; Na+ is an inhibitor of HCS), 20 mM 
α-ketoglutarate, 0.5 mM acetyl-CoA and 0.1 mM DCPIP. All assays were carried out 
at 31 °C. All of the reagents, with the exception of enzyme were incubated for five 
minutes in a water bath for thermal equilibration and to allow for completion of the 
reaction of CoA (in the acetyl CoA solution) with DCPIP. 
Immediately after addition of the enzyme the reduction in blue color of DCPIP 
was monitored for 10 min at 600 nm using a Beckman DU-640 spectrophotometer 
equipped with a circulating water bath to maintain the temperature of the cell 
compartment. The linear portion of the time course following the lag to establish 
steady state (usually in the range of 2-4 min) was used to estimate the steady state rate. 
 
2-2-4. Stoichiometry of the Reaction of DCPIP with CoASH 
A Beckman analytical HPLC system Gold Nouveau equipped with model 168 
detector and model 126 solvent module and operated by GOLD Nouveau 1.7 software 
was used to analyze the reaction of DCPIP with CoASH. The mobile phase buffer was 
a solution of tetrabutylammonium dihydrogen phosphate, pH 7.5, used at a flow rate 
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 of 1 ml/min. The column was an Alltech Adsorbosphere HS C18 7µ hydrophobic 
column. A 100µl mixture of DCPIP and CoASH (0.25 mM and 0.75 mM, 
respectively) was loaded onto the column and the components were eluted using a 
gradient of the running buffer with acetonitrile from 35-85% for 30 min. The same 
experiment was carried out with DCPIP and CoASH separately as controls. The 
decrease in the blue color of DCPIP upon reaction with CoASH in a ratio of 2:1 was 
followed spectrophotometrically in a separate reaction to monitor reaction progress. 
 
2-2-5. Stabilization of HCS 
A variety of solvents and additives at different concentrations, alone and in 
combination, were added to the storage buffer, and the solutions (in 250 µl aliquots) 
were then stored at 4 °C. The effect of the additives on enzyme stability was checked 
by daily enzyme assay for one week. Enzyme activity was also determined for some 
frozen (-20 °C and -80 °C) and thawed samples. Co-solutes and their final 
concentrations are shown in Table 2-1. In this table, X indicates addition of one or two 
co-solutes at the concentrations given. A Y in a row is an indicator that all of the 
possible combinations of the three or four co-solutes at the concentrations shown were 
used. For example, row 16 contains 6 Ys and thus nine combinations of three co-
solutes were used for the experiment at the concentrations given. Mathematically, 
these combinations can be shown as follow: a (b + c + d) (e + f + g) where a is 0.1 M 
GdmCl, b, c and d are 30, 60 and 120 mM α-cyclodextrin and e, f and g are 0.1, 0.3 
and 0.6 M (NH4)2SO4, respectively. A Z is used in a column in a manner similar to Y 
50
 in a row. α-Cyclodextrin begins to form a precipitate under the above conditions at 
temperatures less than 30 °C (especially at 4 °C). Enzyme solutions can be incubated 
in a water bath (30 °C) to just dissolve the precipitate, but not longer, since the 
enzyme begins to lose activity. 
 
2-2-6. Size exclusion chromatography - HPLC 
The Beckman analytical HPLC system was used to analyze the HCS physical 
size. The running buffer was a solution of 100 mM KH2PO4 and 100 mM K2SO4, pH 
7.5. The flow rate was set to 0.25 ml/min. The column used was a PVC-column, LKB-
3000, TSK G3000SW with a Mr fractionation range of 10,000-500,000. A 50 µl (7 
mg/ml) sample of HCS (50 kDa/monomer) was loaded onto the column and 30 
fractions were collected over a chromatogram time of one hour. The standards for 
molecular mass determination were blue dextran (2000 kDa), alcohol dehydrogenase 
(ADH) from yeast (150 kDa), bovine serum albumin (BSA) (66 kDa), and carbonic 
anhydrase from rabbit erythrocytes (29 kDa). Samples of 50 µl of each were loaded at 
the following concentrations: 20 mg/ml, 8.8mg/ml, 6.5 mg/ml and 12 mg/ml, 
respectively. Elution was monitored at 280 nm. 
 
2-2-7. Fluorescence studies of HCS 
Fluorescence spectra were measured as indicated for quenching studies. The 
emission monochromator was scanned either from 290-400 nm or from 310-400 nm 
51
 (with the excitation monochromator fixed at either 278 or 298 nm). Excitation spectra 
were measured from 220-320 nm at a fixed emission wavelength of 350 nm. 
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 Spectra were recorded on a Shimadzu RF-5301 PC spectrofluorometer equipped 
with a special cuvette holder for maintaining the temperature at 25 °C using a 
circulating water bath. A 1 ml quartz cuvette with a path length of 1 cm was used to 
take both the sample (1 ml) and blank spectra. The excitation slit width was set to the 
minimum 1.5 nm and that of the emission was set to 5 nm. Blank spectra contained all 
components except the enzyme (220 µg/ml) and were subtracted from sample spectra. 
Peak heights were obtained after smoothing the spectrum using the available software 
for operating the fluorometer. 
For fluorescence quenching studies, a typical final buffer composition used to 
measure the spectra contained 55 mM Hepes (adjusted to pH 7.5 with KOH), 150 mM 
(NH4)2SO4, 25 mM GdmCl, 25 mM α-cyclodextrin, 8 mM KCl and 5 mM imidazole. 
All samples contained enzyme at a concentration of 55 µg/ml. Compounds used for 
quenching studies were KI (anionic quencher), CsCl (cationic quencher) and 
acrylamide (neutral quencher). Quenchers were added sequentially from low to high 
concentration to both the blank and sample from a stock solution of 2 M for KI, 7.5 M 
for CsCl and 2 M for acrylamide. The final total dilution in each case was 1.09 (KI), 
1.12 (CsCl) and 1.10 (acrylamide). The stock solution of the enzyme used for 
fluorescence quenching studies contained 100 mM α-cyclodextrin, 600 mM 
(NH4)2SO4, 100 mM GdmCl, 30 mM KCl, 20 mM imidazole, 22 mM Hepes, pH 7.5 
and 220 µg/ml HCS. The first three components of the stock solution are required to 
stabilize the enzyme. A final dilution of 4 with 50 mM Hepes is required to dissolve 
the precipitated α-cyclodextrin and to decrease inner filter effects. 
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 2-2-8. Circular dichroism studies 
Circular dichroic spectra were measured at room temperature using an upgraded 
AVIV 62DS CD spectrometer. Spectra were obtained in a 0.2 cm quartz cuvette with a 
sample volume of 0.5 ml. The HCS concentration was 250 µg/ml (5 µM enzyme 
protomer) in a buffer containing 20 mM KH2PO4, pH 7.5 and 300 mM KCl. The blank 
contained all the components except the enzyme. The time constant and bandwidth 
were maintained at 100 ms and 3 nm, respectively. An average of eight scans were 
analyzed (four samples were scanned with two scans per sample). The averaging and 
dwell time were set at 1 s. The spectra were measured from 180-250 nm at 1 nm 
intervals. 
 
2-2-9. Ultraviolet spectra 
Ultraviolet absorption spectra were recorded at 25 °C on a Beckman DU-640 
spectrophotometer. The HCS concentration was 830 µg/ml in Ni-NTA elution buffer 
(20 mM Hepes pH 7.5, 300 mM KCl and 200 mM imidazole). Addition of GdmCl 
(4.8 M final) was used to denature the enzyme for 5 minutes at 45 °C. The native and 
denatured HCS samples were scanned from 400 nm to 240 nm and the difference 
spectrum was obtained. The Blank contained all components except the enzyme. 
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2-3. Results and discussion 
2-3-1. Cell growth and protein expression 
The expression of HCS is very good under conditions used to induce expression. 
The HCS produced in the expression system is about 20% of the total soluble proteins. 
After washing with 20 mM imidazole, the enzyme is eluted from the Ni-NTA column 
from 60 to 180 mM imidazole with the highest concentration eluting at 60 - 90 mM. 
The purity of the eluted HCS from the Ni-NTA column is ≥ 80% (by densitometric 
scanning). The amount of the enzyme obtained is 8 – 10 mg from 500 mg wet cell 
pellet (200 ml cell culture). As shown in Fig. 2-2, if the column is initially washed 
with 50 mM imidazole the enzyme can be further purified to 98% without any 
significant decrease in yield. On the basis of several purifications, the fold purification 
Fig. 2-2: SDS-PAGE of HCS stained with Coomassie brilliant blue (left). Densitometry scanning 
(right) shows that the enzyme is about 98% pure. 
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 is 2-5 with a yield 60-120% (the value >100% suggests there may be inhibitors of the 
HCS in the crude extract). Although HCS has a histidine tag, it is still active. The 
histidine tag is readily cleaved by rTEV protease as shown by SDS-PAGE (data not 
shown). However, inhibitors (EDTA, DTT and Triton X-100) present in the protease 
storage buffer interfered with HCS activity. The buffer was exchanged with HCS 
buffer making use of the His-tag on the protease. The rTEV protease still cleaved the 
His-tag of the HCS, but also gave nonspecific proteolysis of the enzyme. The resulting 
enzyme was still active but with reduced activity compared to the His-tagged enzyme 
(see below). 
 
2-3-2. Enzyme assay 
The most common assay for enzymes that produce CoASH as a product makes 
use of a disulfide exchange reaction between DTNB and CoASH, which yields 5′-
thio-2-nitrobezoate (ε412 nm = 13.6 mM−1cm−1). However, preincubation of HCS with 
DTNB for 15 min, results in a complete inactivation of the enzyme. On the other hand, 
the DCPIP method is a good continuous monitor of HCS activity (11) and the activity 
is a linear function of enzyme concentration in the range of 0-0.3 dA/min (data not 
shown). Preincubation of HCS with DCPIP for 15 min has no effect on activity. A 
solution of DCPIP can be used up to 3 weeks, after which inhibitors/inactivators are 
present in the solution. The small amount of Na+ in the acetyl-CoA and DCPIP 
solutions has no effect on enzyme activity for the concentrations used in the assay. 
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 Kinetic parameters for the HCS are summarized in Table 2-2. The range of Km(α-
kg) and Km(AcCoA) values for HCS from other sources are 2.2 - 11.8 and 0.06 - 0.2 
mM, respectively (14). The kcat for HCS from Thermus thermophilus is 75 min-1 (14). 
As shown in Table 2-2, the one year old stabilized HCS still has about 50% of its 
activity when isolated, while the His-tag-cleaved enzyme has lost 90% of its activity. 
However, the Km values for all enzymes are identical within error suggesting a loss of 
active enzyme, with the remaining active enzyme behaving in a manner identical to 
the freshly isolated and stabilized His-tagged enzyme. It thus appears that 1) less 
active conformers of the HCS are unlikely, and 2) the His-tag has no influence on the 
activity of the HCS. 
 
Table 2-2: Kinetic parameters for homocitrate synthase (graphical analysis). 
 
Enzymea 
 
Substrate 
Km 
(mM) 
kcat 
(min-1) 
Specific 
Activity 
(mU/mg) 
α-ketoglutarate 4.6 37 730 1 
acetyl-CoA 0.014   
α-ketoglutarate 1.3 37 730 2 
acetyl-CoA 0.024   
α-ketoglutarate 0.7 17 350 3 
acetyl-CoA 0.021   
α-ketoglutarate 1.8 3 45 4 
acetyl-CoA 0.026   
a1. HCS without stabilization buffer; 2. HCS plus stabilization buffer; 3. 2 after 1 yr storage at 
4oC; 4. His tag-cleaved HCS. Standard errors of the parameters are <10%. 
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 2-3-3. Stoichiometry of the reaction of DCPIP with CoASH 
Spectrophotometric measurements showed that the stoichiometry of the reaction 
of DCPIP (15) with CoASH is 1:1 (see Appendix – Fig. A-1). The analytical HPLC 
results showed the formation of an unidentified CoA species as the result of the 
reaction (Fig. 2-3). The unidentified form of the CoA may be an oxidized form of the 
CoA-S-S-CoA molecule or a DCPIP-CoA adduct. The above will require additional 
study. 
 
2-3-4. Stabilization of HCS 
Protein stability depends on a subtle interaction of the protein with water and 
Fig. 2-3: (A) Analytical HPLC trace of 1.5 mM CoASH. The first peak is the linear CoASH and 
the second peak is likely the cyclic (thiazoline) form of the CoASH (30) (B) Trace of the reaction 
mixture of 0.75 mM CoASH and 0.25 mM DCPIP. The second two peaks are the two new forms 
of the oxidized CoASH dimer. 
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 other solute molecules, including ionic interactions between the surface of the protein 
and water dipoles, hydrophobic interactions with other solute molecules, and hydrogen 
bonding with water and other solute molecules. In designing a protocol to determine 
conditions to stabilize a protein, different classes of co-solutes capable of affecting one 
of the interactions listed above were chosen (16). Polyols and sugars like sorbitol and 
sucrose can stabilize the lattice structure of water and also increase the viscosity. 
Polymers like PEG prevent protein aggregation by increasing solvent viscosity. Amino 
acids like glutamic acid are capable of increasing the surface tension of water and give 
also electrostatic interaction with polar groups on the protein surface. Ionic 
compounds like (NH4)2SO4 are useful for surface charge shielding, while denaturing 
agents like urea stabilize the unfolded state of the protein, providing a better 
opportunity for the proper refolding. GdmCl is a chaotrophic agent that disrupts 
hydrogen bonds and the hydration shell around protein. DTT can be used to maintain 
free sulfhydryls in a reduced state, while PMSF and EDTA are protease inhibitors 
(16). 
Cyclodextrins (and their derivatives) are of particular interest. The 3D structure of 
these molecules suggests a cone that has a hydrophobic interior and a hydrophilic 
exterior. α-Cyclodextrin is capable of binding to hydrophobic areas of the protein to 
render it more hydrophilic. In equilibration with denaturing agents, α-cyclodextrin 
also acts as an adsorbent that gradually adsorbs the denaturing agents from the surface 
of the protein and provides the protein with proper local conformational refolding. 
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 This mechanism is similar to chaperone-assisted renaturation that has been used to 
renature some proteins from the denatured state (12-13). 
Experiments to determine conditions that will stabilize the highly unstable 
enzyme were quite successful. Sucrose, glutamic acid, sorbitol, glycerol and α-
ketoglutarate have no effect on HCS stability, and α-cyclodextrin and (NH4)2SO4 also 
have no effect if used alone. Combinations of (NH4)2SO4 and sorbitol, sucrose and 
PEG-1500, sucrose and glutamic acid, GdmCl and (NH4)2SO4, or GdmCl and α-
cyclodextrin also have no effect on stability. 2-Methyl-2, 4-pentanediol alone or in 
combination with other co-solutes inactivates the enzyme. Dithiothreitol at a 
concentration of 1 mM inactivates the enzyme, while a concentration of 0.1 mM gives 
only slight inactivation. Preincubation of HCS with 1 mM PMSF for five minutes 
decreases the activity of enzyme by 20%, while 100 mM α-cyclodextrin plus 0.01% 
SDS stabilizes the enzyme to some extent. 
Preliminary studies showed that a combination of 100 mM α-cyclodextrin, 300 
mM (NH4)2SO4 and 100 mM GdmCl gives the best stability. More detailed 
experiments showed that in this combination (NH4)2SO4 and GdmCl can not be 
replaced by NH4Cl and urea, respectively. In addition, Gdm sulfate is not a 
replacement for GdmCl and (NH4)2SO4, and surprisingly Gdm sulfate is a potent 
destabilizing agent. Data suggest a role for NH4+ in stabilizing HCS. Therefore, it is 
concluded that the combination of three co-solutes (100 mM α-cyclodextrin, 100 mM 
GdmCl and 600 mM (NH4)2SO4) is needed for HCS stability and stabilization is 
optimum at higher concentration of these co-solutes. 
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 Screening against different concentrations of KCl showed that in the presence of 
600 mM (NH4)2SO4, 300 mM KCl has a destabilizing effect, but lower concentrations 
of KCl stabilize (See Appendix – Fig. A-2). Other components of the stabilization 
stock solution are 30 mM KCl, 20 mM imidazole and 22 mM Hepes, pH 7.5 (from the 
Ni-NTA column elution buffer). Upon storage at 4 °C, the enzyme is stable up to 50 
days, with very little decrease in activity (See Appendix – Fig. A-3). The half lives of 
the stabilized and non-stabilized HCS are 180 and 5 days, respectively. 
 
2-3-5. Size exclusion chromatography – HPLC 
Results showed that the enzyme elutes from the column over a broad range and is 
fractionated into several peaks. Activity is found in most of the fractions with the 
highest activity in the lowest molecular mass form. Comparison of the elution profile 
with that of the standards suggests that HCS may be present in a number of different 
forms including the monomer, dimer, tetramer and higher molecular mass aggregates 
(Fig. 2-4). The higher molecular mass forms are likely aggregates, suggesting the 
enzyme has a high potential for self-association at higher concentration. The exact Mr 
of the different forms of the HCS enzyme was not obtained as a result of interaction of 
the enzyme with the column. Estimation of the molecular mass of the different species 
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 eluting from the gel filtration column, on the basis of the elution profile of the 
standards, gives the following estimated molecular mass at the retention time listed: 4 
kDa (51.3 min), 18 kDa (43.6 min), 68 kDa (37.6 min), 270 kDa (31.5 min), 550 kDa 
(27.7 min) and 2200 kDa (21.4 min). The peaks show a preferred multiplicity of four 
suggesting a trend in the self-association properties. A non-spherical or highly 
asymmetric three dimensional structure may contribute to the interaction of the HCS 
with the column. These studies will be followed up using the analytical 
ultracentrifuge. 
Fig. 2-4: Elution profile of the HCS suggests the enzyme may be present in a number of different
self-associated forms. The position of standards for molecular mass determination has been 
shown as arrows. From left to right arrows 1 to 4 are Blue dextran (2000 kDa) (23.0 min), ADH
from yeast (150 kDa) (31.3 min), BSA from bovine (66 kDa) (36.7 min), and carbonic anhydrase
from rabbit erythrocytes (29 kDa) (44.0 min), respectively. 
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 2-3-6. Fluorescence studies of HCS 
The excitation spectrum of the HCS shows the typical ultraviolet absorption 
spectrum of tryptophan suggesting that the spectrum of the HCS is dominated by 
contribution of the tryptophan residue (17). The fluorescence emission spectrum, with 
excitation at 278 nm, shows a λmax of 337 nm and a shoulder at 307 nm, Fig. 2-5A. 
Normalization of the emission spectrum with excitation at 298 nm to the same 
intensity of the emission spectrum obtained upon excitation at 278 nm shows that 
tyrosine residues contribute about 35% to the total fluorescence in the blue region of 
the emission spectrum; Fig. 2-5A, and the remainder of the fluorescence is from the 
single tryptophan residue (data not shown). The 298 nm emission spectrum, 
originating from the single Trp, shows a λmax at 337 nm. According to Burstein, who 
has classified the emission properties of tryptophan residues in proteins (18-20), the 
position of the λmax for emission spectra of the tryptophan residues in proteins varies 
from 307 to 353 nm (five spectral classes A, S, I, II and III). The blue extreme (307 
nm) or tryptophan spectral form A indicates an unperturbed indole chromophore in a 
nonpolar environment inside the protein. The red extreme (353 nm) or tryptophan 
spectral form III corresponds to the indole chromophore at the surface of the protein in 
contact with free water molecules. The HCS emission spectrum belongs to the spectral 
form II that corresponds to the emission of the indole chromophore near the surface of 
the protein. The tryptophan residue is assumed to be in contact with the bound water 
(not free water molecules) and other polar groups of the protein. 
 
64
 Fluorescence quenching data were analyzed using the Stern-Volmer plot (F0/F 
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Fig. 2-5: (A) Fluorescence excitation spectrum of HCS (❑) taken at fixed emission wavelength of 
350 nm and emission spectra of HCS taken at excitation wavelength of 278 nm (∆) and 298 nm 
(◊). (B) CD spectrum of HCS. (C) U.V. spectrum of native (—) and denatured (---) HCS. 
Difference spectrum between native and unfolded HCS is shown in inset. 
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 vs.[Q]) and the modified Stern-Volmer plot (F0/∆F vs. 1/[Q]) (Fig. 2-6). The modified 
Stern-Volmer equation is F0/∆F = (faKSV[Q])-1 + (fa)-1 where F0 is the fluorescence 
intensity in the absence of quencher, ∆F is the change in fluorescence intensity in the 
presence of quencher, KSV is the Stern-Volmer constant, [Q] is the concentration of 
quencher and fa is the fraction of the total fluorescence of the enzyme that is accessible 
to quenching (21). The KSV and fa values are shown in Table 2-3. The KSV and fa were 
determined by monitoring the fluorescence spectra measured upon excitation at 
298nm. These data are the most reliable because the emission results from the single 
Trp of HCS alone. 
 
Table 2-3: Fluorescence quenching parameters for homocitrate synthase 
Quencher KSV 
 
KI (25 °C) 
 
 
KSV = 10.3 M-1, fa = 34% 
 
 
KI (35 °C) 
 
 
KSV = 7.8 M-1, fa = 40% 
 
 
CsCl (25 °C) 
 
 
KSV = 5.6 M-1, fa = 11% 
 
 
CsCl (35 °C) 
 
 
KSV = 1.1 M-1, fa = 23% 
 
 
Acrylamide (25 °C) 
 
 
KSV = 6.2 M-1, fa = 59% 
 
 
Acrylamide (35 °C) 
 
 
KSV = 3.7 M-1, fa = 77% 
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Fig. 2-6: Modified Stern-Volmer plot for KI (A), CsCl (B) and Acrylamide (C) at 25 °C. X-
intercept = - KSV, Y-intercept = fa-1 and the slope is equal to (faKSV)-1. Stern-Volmer plots are shown 
in insets. 
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 An upward curvature in the Stern-Volmer plot results from a combination of static 
and dynamic quenching and has two possibilities regarding the KD (dynamic 
quenching constant) and KS (static quenching constant) values. However, fluorescence 
lifetime measurements are needed to elucidate the real KD and KS. A downward 
curvature in the Stern-Volmer plot results from a combination of two different 
conformers that differ in their accessibility of the fluorophores to the quencher (21). 
By definition (KSV)-1 is the quencher concentration at which 50% of the fluorescence 
intensity is quenched. Although Cs+ is smaller than I− (ionic radii are 165 and 220 pm, 
respectively (22)), I− is the best quencher and it suggests that the microenvironment 
around tryptophan is positively charged. Quenching of HCS by KI, CsCl and 
acrylamide shows a downward curvature in the Stern-Volmer plot and a decrease in 
the KSV values upon increasing the temperature, but fluorophore lifetime 
measurements are needed to distinguish between static and dynamic quenching 
because of the nonlinear dependence of the quenching on quencher concentration. 
 
2-3-7. Circular dichroism studies 
The CD spectrum of HCS, Fig. 2-5B, shows a typical protein spectrum with 
minima at 222 nm and 208 nm suggesting the presence of α and β secondary structural 
components. The protein type seems to be α/β because the 208 nm band is of lower 
intensity than 222 nm band (in α + β proteins the 208 nm band is of higher intensity 
than 222 nm band (23)), consistent with multiple sequence alignment data that suggest 
a TIM barrel fold at the N-terminal part of the HCS (24). The C-terminal part of the 
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 HCS is likely to possess a regulatory cyclin-like, EF-hand-like fold and may possess a 
DNA-binding motif as indexed using the 3D-PSSM program (25). However, precise 
conclusions await the determination of the structure. 
Experimental data could not be collected at wavelengths less than 200 nm due to 
absorbance of the stabilizing buffer. As a result, deconvolution of the spectrum into its 
components could not be carried out. Predicted secondary structure composition using 
the PROF (Profile network prediction heidelberg) network prediction (26-27) shows 
that the original HCS (without histidine tag) contains 41% α-helix, 17% β-sheet and 
42% coil structure, while the His-tagged HCS contains 38% α-helix, 17% β-sheet and 
45% coil structure. Estimation of the α-helical content of the His-tagged HCS on the 
basis of the mean residue ellipticity at 222 nm (fraction α-helix = (− [θ] 222 nm + 
3000)/39000) (28) gives a value of 20%. The low mean residue rotation of the HCS 
may be due to a small amount of periodic secondary structure or cancellation of β-
sheet and random coil contributions (29). 
 
2-3-8. Ultraviolet spectra 
U.V. spectra of native and denatured HCS are shown in Fig. 2-5C. The difference 
spectrum between native and unfolded HCS is shown in the inset. The prominent 
peaks at 281 and 289 nm in the difference spectrum are due to solvent exposure of the 
tyrosine and tryptophan residues, respectively, suggesting that the HCS is easily 
denatured on the basis of the conditions used for denaturation. The theoretical 
extinction coefficient of the denatured His-tagged HCS at 280 nm was calculated to be 
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 24090 M−1cm−1 using the ProtParam tool at the ExPASy website 
(http://us.expasy.org/tools/protparam.html). The experimental ε280 nm for denatured and 
native His-tagged HCS was calculated as 26800 and 29200 M−1cm−1, respectively. 
 
2-4. Conclusion 
The purified homocitrate synthase (HCS) from Saccharomyces cerevisiae can be 
stabilized using a combination of guanidine hydrochloride, α-cyclodextrin and 
ammonium sulfate. The histidine tag at the N-terminal of the HCS can be used to 
purify the enzyme and is cleavable by rTEV protease. The fluorescence and CD 
spectra suggest a partially exposed tryptophan residue and a mixed secondary 
structure. The fluorescence quenching studies suggest a positively charged 
microenvironment around the single tryptophan residue. 
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 CHAPTER 3 
Kinetic mechanism of homocitrate synthase 
 
 
“Reproduced with permission from [Andi, B., West A. H., and Cook, P. F. (2004) Kinetic Mechanism of Histidine-Tagged 
Homocitrate Synthase from Saccharomyces cerevisiae, Biochemistry 43, 11790-11795] Copyright [2004] American Chemical 
Society.” 
 
3-1. Introduction 
Homocitrate synthase (HCS) [2-hydroxybutane-1,2,4-tricarboxylate 2-
oxoglutarate-lyase (CoA-acetylating), EC 2.3.3.14] is the first and regulated enzyme 
of the α-aminoadipate pathway for the biosynthesis of lysine. The pathway is unique 
to higher fungi such as the human pathogens Candida albicans, Cryptococcus 
neoformis and Aspergillus fumigatus and the plant pathogen Magnaporthe grisea. The 
uniqueness of the α-aminoadipate pathway makes it a potential target for the design of 
the highly specific antimycotic agents (1-5). 
The pathway begins with the condensation of α-ketoglutarate with AcCoA to 
yield homocitrate and coenzyme A with the intermediacy of a homocitryl-CoA 
intermediate (2-5). There are two isozymes of HCS from Saccharomyces cerevisiae 
(cytosolic and mitochondrial), and both are feedback inhibited by lysine, the pathway 
end product, and the expression of the cytosolic isozyme is repressed by lysine (6). 
HCS activity may also be regulated by divalent metal ions in the presence of CoA (7). 
There are few studies on the kinetic mechanism of the HCS. An ordered kinetic 
mechanism has been proposed for the HCS from Saccharomycopsis lipolytica with α-
ketoglutarate binding before AcCoA (8). The authors reported a sigmoid saturation 
74
 curve for AcCoA. A sigmoid saturation curve for AcCoA was also reported for the 
enzyme from Penicillium chrysogenum (9). It has been also demonstrated that the 
HCS from Thermus thermophilus is capable of catalyzing the reaction using 
oxaloacetate in place of α-ketoglutarate as a substrate, and thus behaves as a citrate 
synthase (10). 
The HCS from Saccharomyces cerevesiae is unstable as isolated (11). 
Stabilization of the HCS from S. cerevisiae provided us with an enzyme with a longer 
half-life (11) making it possible to carry out detailed kinetic studies. In this paper, we 
report the kinetic mechanism of the HCS from S. cerevisiae. 
 
3-2. Materials and methods 
3-2-1. Materials 
All chemicals were of the highest grade commercially available. α-Ketoglutarate, 
oxaloacetate, citrate, dichlorophenol indophenol (DCPIP), AcCoA, CoA, desulfo-
CoA, α-cyclodextrin, L-glutamate, succinic acid and γ-ketopimelate were obtained 
from Sigma. KCl, GdmCl and glycerol were purchased from Fisher Scientific. 
(NH4)2SO4 was obtained from Fluka and Hepes was from Amresco. Imidazole was 
obtained from Research Organics. 
The concentrations of AcCoA, CoA and desulfo-CoA were adjusted 
spectrophotometrically (ε260, 16.4 mM-1cm-1). A solution of AcCoA in ddH2O is 
stable, without any significant hydrolysis, for at least a month if kept at -21°C. The 
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 concentration of DCPIP preparations was also adjusted spectrophotometrically (ε600, 
19.1 mM-1cm-1). 
 
3-2-2. Assays of homocitrate synthase activity 
Cell growth, HCS expression and purification were performed as previously 
described (11). A typical assay for the HCS using the DCPIP method (monitoring the 
decrease in absorbance at 600 nm upon DCPIP reduction) is as described with slight 
modifications (11). The final volume of the assay was 0.5 mL and contained 50 mM 
Hepes, pH 7.5 (adjusted by KOH), and variable concentrations of α-Kg and AcCoA 
(~Km or ~20Km) and 0.1 mM DCPIP. All assays were carried out at 25 °C. Reactions 
were thermally equilibrated to allow for completion of the reaction between the small 
amount of CoA in the AcCoA solution and DCPIP before adding the enzyme to the 
reaction mixture. It should be noted that inhibition patterns for CoA could not be 
studied using DCPIP assay. Therefore, the disappearance of absorbance at 232 nm 
(reflecting the thioester bond of AcCoA) was monitored in these cases (11). The 
decrease in absorbance at 232 nm (∆ε232 = 4.5 mM-1cm-1) was monitored upon 
addition of the HCS using the 0.4 cm path length cuvette (NSG Precision Cells, Inc.). 
In order to dissolve the precipitated α-cyclodextrin in the stabilized HCS 
suspension (11) glycerol was added to a final concentration of 10%. A dilute enzyme 
solution prepared using this method is stable at room temperature up to three hours 
after which, the enzyme begins to lose activity. 
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 3-2-3. Initial velocity studies 
As described in the enzyme assay section, the DCPIP method was used to study 
initial velocity patterns with the exception of those in which CoA was present. The 
initial rate was measured as a function of AcCoA concentration (0.0125-0.125 mM) 
and a fixed concentration of α-Kg and the experiment was then repeated at several 
additional α-Kg concentrations (1-10 mM). A similar experiment was carried out with 
OAA (10-50 mM) in place of α-Kg using the same variable concentrations of AcCoA 
at different fixed concentrations of OAA. Data in both cases were fitted to Eq. 1 for a 
sequential mechanism as represented using Cleland’s nomenclature (12). 
 
ABAB
AB
+++= babia
Vv
KKKK
       (1) 
 
where v and V are initial and maximum rates, A and B are reactant concentrations, Kia 
is the dissociation constant for A, and Ka and Kb are the Michaelis constants for A and 
B, respectively. 
A point that must be considered when carrying out inhibition studies is related to 
the effect of monovalent ions on the HCS reaction. The behavior of HCS is 
complicated in the presence of monovalent and divalent cations (see Chapter 4). The 
major source of these ions is from the titrant used to adjust the pH of buffer and 
carboxylic acid substrate solutions. In addition, the presence of NH4+ in the 
stabilization buffer for HCS (11) is a source of monovalent ions. The activating effect 
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 of the NH4+ is obvious in Figure 3-1 at the lowest α-Kg concentration where the 
reciprocal values of the experimental data points are lower than the predicted values 
(solid line). This effect introduces some (manageable) error in data analysis. In 
general, when monovalent cations are not a subject of kinetic studies, their 
concentration should not exceed 50 mM. 
 
3-2-4. Inhibition studies 
Inhibition patterns were obtained by measuring the initial rate at different 
concentrations of one reactant, a fixed concentration of the second reactant equal to 
Km, and a fixed concentration of the inhibitor. The experiment was then repeated at 
several different fixed concentrations of the inhibitor (including zero). Dependent on 
whether the inhibition was competitive, noncompetitive or uncompetitive, data were 
fitted to Eqs. 2-4. 
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78
 In Eqs. 2-4 Kis and Kii are slope and intercept inhibition constants, respectively, I is the 
concentration of inhibitor, and all other terms are as defined above. 
 
3-2-5. Fluorescence determination of the HCS-ligand dissociation constant 
Fluorescence spectra were measured as previously described (11). Emission 
spectra were measured from 310-400 nm with the excitation monochromator fixed at 
298 nm. Spectra were recorded on a Shimadzu RF-5301 PC spectrofluorometer 
equipped with circulating water bath to maintain the temperature at 25°C. 
Fluorescence quartz cuvettes with a volume of 1 mL and a path length of 1 cm were 
used to measure sample and blank spectra. Excitation and emission slit widths were 
set to 1.5 nm and 5 nm, respectively. Because all of the reagents and buffer 
components have no absorbance above 310 nm, the inner filter effect is negligible 
under conditions used for taking the spectra. 
The final buffer composition used to measure the spectra contained 55 mM Hepes 
(adjusted to pH 7.5 with KOH), 150 mM (NH4)2SO4, 25 mM GdmCl, 25 mM α-
cyclodextrin, 8 mM KCl and 5 mM imidazole. All samples contained enzyme at a 
concentration of 55 µg/mL. Compounds used for fluorescence studies were α-Kg, 
OAA, AcCoA and CoA that were added sequentially from low to high concentration 
to both the blank and sample from a stock solution of 1 M for α-Kg, 100 mM for 
OAA, 5 mM for AcCoA and 8.6 mM for CoA. The final total dilution in each case 
was 1.07 (α-Kg), 1.08 (OAA), 1.10 (AcCoA) and 1.06 (CoA), and all the data were 
corrected for dilution. 
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 To calculate the Kd based on the fluorescence intensity, data were fitted to the 
equation for a rectangular hyperbola shown in Eq. 5 
 
L
L
+
∆=∆
d
max
K
FF           (5) 
 
where ∆F is the change in intrinsic tryptophan fluorescence upon addition of ligand to 
enzyme, ∆Fmax is the maximum change in fluorescence at infinite ligand 
concentration, L is the ligand concentration and Kd is the dissociation constant for the 
enzyme-ligand complex. 
 
3-2-6. Data analysis 
Initial rates and fluorescence intensity changes were plotted as reciprocal plots vs. 
substrate or ligand concentration, and all plots and replots were linear. Data were fitted 
using the appropriate equations and the Marquardt-Levenberg algorithm supplied with 
the EnzFitter program from BIOSOFT, Cambridge, UK. Rate, kinetic and dissociation 
constants and their corresponding standard errors were estimated using a simple robust 
weighing method for the activity or affinity of the enzyme by fitting the curves to the 
data either in the absence or presence of inhibitors or ligands. 
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 3-3. Results 
3-3-1. Initial velocity studies 
The initial velocity pattern obtained varying the concentration of α-Kg at different 
fixed concentrations of AcCoA is shown in Fig. 3-1. The lines intersect to the left of 
the vertical axis consistent with the sequential Bi Bi mechanism (13). Data could not 
be obtained in the reverse reaction direction because of the irreversibility of the 
reaction (see below). However, the inhibition patterns provide a great deal of 
information about the sequential mechanism. 
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Fig. 3-1: Initial velocity Double-reciprocal Plot for the HCS reaction. The concentrations of AcCoA 
are as plotted, while α-Kg is fixed at 10 mM (◆), 2.5 mM (■), 1.46 mM (▲), and 1 mM (●). The 
solid lines are theoretical data based on the fit to equation 1, while the points are experimental.
Note that the experimental values measured using 1 mM α-Kg are higher than the predicted values 
due to the activating effect of monovalent cations on the HCS (see Chapter 4). 
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 An intersecting pattern is also observed when OAA is used as a α-Kg substrate 
analog (see Appendix – Fig. A-4). Thus, HCS is capable of catalyzing a reaction that 
is specific to citrate synthase from the TCA cycle, although homocitrate synthase has 
no homology to citrate synthase in terms of sequence and probably three-dimensional 
structure (citrate synthase has an all-helical structure while the structure of 
homocitrate synthase is predicted to contain an α/β TIM barrel domain (11, 14)). 
Kinetic parameters for HCS using either α-Kg or OAA are shown in Table 3-1. 
Table 3-1: Kinetic parameters for HCS. 
Parameter A = α-Kg A = OAA 
Ka (mM) 3.3 ± 0.2 25.5 ± 0.1 
Kb (µM) 2.4 ± 0.2 1.30 ± 0.01 
Kia (mM) 25.1 ± 2.5 140 ± 1 
V/Et (s-1) 0.60 ± 0.03 0.30 ± 0.02 
V/KaEt (M-1⋅s-1) 180 ± 14 9.8 ± 0.7 
V/KbEt (M-1⋅s-1) (2.5 ± 0.2) × 105  (2.0 ± 0.1) × 105 
 
The V/Et values obtained with α-Kg and OAA are very similar, but V/KEt values 
differ by more than an order of magnitude with V/Kα-KgEt > V/KOAAEt. There is no 
difference in terms of specificity of the HCS for AcCoA using either α-Kg or OAA. 
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 3-3-2. Product inhibition studies 
The only product inhibition patterns obtained were with CoA, which is UC vs. α-
Kg and NC vs. AcCoA, Table 3-2.  The Ki of 20 µM for CoA suggests it still binds 
with reasonably high affinity without the acetyl group. 
 
3-3-3. Dead-end inhibition studies 
Based on preliminary studies, HCS did not show any detectable inhibition by 10 
mM L-glutamate, 50 mM γ-ketopimelate, or 50 mM succinate (data not shown). 
Dead-end inhibitors are invaluable in establishing order of binding in an enzyme 
mechanism (13). Desulfo-CoA was used as a dead-end analog of AcCoA, and is NC 
against AcCoA, and UC against α-Kg. The uncompetitive inhibition against α-Kg 
suggests an ordered mechanism with α-Kg binding prior to AcCoA. The 
noncompetitive inhibition by CoA and desulfo-CoA suggest two combinations by the 
two inhibitors, one identical to the enzyme form to which AcCoA combines, and a 
second on the product side of the reaction, likely the E:Hc form of the enzyme. The 
lack of a slope effect in the case of the inhibition by CoA with α-Kg varied at a low 
AcCoA concentration suggests an irreversible reaction consistent with the downhill 
nature of the reaction as a result of the hydrolysis of the intermediate homocitryl-CoA. 
Citrate was used as a dead-end analog of α-Kg, and is C vs. α-Kg and NC vs. 
AcCoA. Data are consistent with the proposed ordered addition of α-Kg before 
AcCoA with a dead-end E:α-Kg:CoA complex. All kinetic constants are summarized 
in Table 3-2. 
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 3-3-4. Fluorescence studies 
In order to further test the proposed kinetic mechanism, fluorescence titrations 
were utilized to estimate the dissociation constants for enzyme-reactant complexes. 
Table 3-3 gives a list of the dissociation constants measured. All of the ligands quench 
the fluorescence emission of the single tryptophan of HCS with the exception of CoA, 
which gives a slight enhancement of fluorescence (11). Although AcCoA binds to free 
HCS, its Kd (450 µM) (Fig. 3-2) is much higher than its Km (2 µM). The Kd for E:α-
Kg, however, is identical within error to the Kia value reported in Table 3-1. Although 
CoA binds better to E than does AcCoA (3-fold), it still has a weaker affinity than it 
does to the E:Hc complex (8-9-fold). Interestingly, the presence of CoA (3-times its 
Kd) decreases the affinity of α-Kg by 4-fold, while OAA binds better to free HCS than 
does α-Kg (7-fold). 
 
Table 3-3. Dissociation constants of ligand-HCS complexes from fluorescence titration. 
 
Ligand Kd (mM) 
α-Kg 26 ± 1 
α-Kg (+0.5 mM CoA) 111 ± 1 
OAA 3.70 ± 0.02 
CoA 0.17 ± 0.01 
AcCoA 0.45 ± 0.01 
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Fig. 3-2: (A) Determination of the Kd for AcCoA via fluorescence titration. A plot of ∆F vs. the 
concentration of AcCoA is shown. The inset shows a double reciprocal plot of the data, with the x-
intercept equal to -1/Kd. (B) Determination of the Kd for CoA via fluorescence titration. The curves 
are theoretical based on a fit to eq. 5, while points are experimental in both cases. 
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 3-4. Discussion 
The initial velocity pattern gives a family of lines that intersect to the left of the 
ordinate suggesting a sequential kinetic mechanism for HCS. The ordered nature of 
the mechanism is suggested by the UC inhibition by desulfo-CoA and CoA vs. α-Kg. 
In both cases these inhibitors are NC vs. AcCoA, the substrate they mimic structurally. 
Data thus indicate the inhibitors combine with two separate enzyme forms, one the 
same as that to which AcCoA binds, the E:α-Kg complex, and a second, likely the 
normal product complex to which CoA binds, E:homocitrate. In a reversible reaction 
binding of CoA to the E:Hc complex would give NC inhibition vs. both substrates in 
an ordered mechanism as a result of reversal of the reaction. In this case, however, 
equilibrium is far to the right as a result of hydrolysis of the intermediate homocitryl 
CoA, and the reaction is practically irreversible. (Homocitrate and CoA are products 
since the absorbance of the thioester bond decreases as AcCoA is used up and the 
appearance of CoA can be monitored using the DCPIP assay (11).) Both CoA and 
desulfo-CoA can thus be treated as dead-end inhibitors. An analog of the first 
substrate bound in an ordered mechanism would be expected to be C vs. α-Kg and NC 
vs. AcCoA, as is observed for citrate. A kinetic mechanism can thus be proposed as 
shown in Figure 3-3. The mechanism is ordered with α-Kg binding before AcCoA and 
with CoA released before Hc. The reaction is practically irreversible and the product 
CoA can bind to the E:α-Kg and E:Hc complexes. 
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3-4-1. Quantitative analysis of inhibition data 
Since all inhibitors, including CoA, can be treated as dead-end inhibitors, 
correction of the observed Ki values for the fixed variable substrate should give the 
same true Ki values whichever of the substrates is varied. The competitive inhibition 
by citrate vs. α-ketoglurate gives the true Ki for the inhibitor for the E:citrate complex, 
14 mM. With AcCoA varied, however, the observed Kis and Kii values must be 
corrected for the concentration of the fixed substrate. Given the rate equation for the 
ordered kinetic mechanism, Eq. 1, the presence of the inhibitor adds a (1 + I/Ki) terms 
to each of the denominator terms representing free enzyme, KiaKb and KaB to give Eq. 
6, where Ki is the intrinsic dissociation constant for EI. 
 
E E:Hc EE:α-Kg (E:α-Kg:AcCoA E:Hc:CoA)
α-Kg AcCoA CoA Hc
E:α-Kg:CoA E:Hc:CoA
k3k2k1 k4 k9 k11
k'5
Fig. 3-3: Proposed kinetic mechanism for the HCS. E represents the HCS. Kinetic data suggest that 
the reaction is irreversible in agreement with the thermodynamics of the reaction.  CoA (and 
desulfo-CoA) can bind to both E:α-Kg and E:Hc forms of the enzyme, while citrate binds to E. k′5
is the net catalysis rate and is defined as k5k7/(k6+k7). 
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With B varied, Eq. 6 in double reciprocal form is given by Eq. 7. 
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The observed or appKi is then obtained from the expressions for slope and intercept 
vs. I when the slope is zero. As an example, the expression for the slope inhibition 
constant is derived below. 
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and with slope equal to zero 
 



 +−==
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ii 1app K
KK AI         [9] 
 
where appKi is the measured Kis value given in Table 3-2. The expression for Kii can 
be derived in a similar manner, and the true Ki can be calculated. The calculated Ki 
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 values of 13 mM and 17 mM agree very well, Table 3-2 (values in parentheses). 
Although, the corrected Kis and Kii values for the inhibition by citrate vs. B (Table 3-2) 
are different, they are the same order of magnitude, and the value obtained from Kii 
has a high error associated with it. 
Inhibition by desulfo-CoA or CoA results from binding to E:α-Kg, represented by 
the KbA term, and a form of the enzyme present at saturating concentrations of both 
reactants, represented by the AB term. Equation 1 can thus be modified as follows to 
give the rate equation for inhibition by either desulfo-CoA or CoA. 
 



 ++


 +++
=
i2i1
babia 11
Vv
KK
KKKK IABIAB
AB      [10] 
 
In eq. 10, Ki1 is the intrinsic Ki for E:α-Kg:I, but Ki2 is an apparent Ki with a value 
determined by the amount of the E:Hc complex that builds up in the steady state at 
saturating substrate concentrations. Values for Ki1 and Ki2 can be evaluated as above, 
from the noncompetitive inhibition vs. AcCoA, giving 1 µM and 20 µM, respectively, 
for CoA, and 2µM and 110 µM, respectively, for desulfo-CoA. Thus, CoA binds 
better by a factor of 2 to E:α-Kg. 
The observed Kii from the UC inhibition pattern obtained for CoA or desulfo-CoA 
vs. α-Kg cannot so easily be evaluated. The expression for Kii is given in Eq. 11. 
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Substituting values for B, Kb, and the calculated values for Ki1 and Ki2 from Table 3-2 
in Eq. 11, gives Kii values of 25 µM and 19 µM for desulfo-CoA and CoA, 
respectively, in excellent agreement with the measured values of 21 µM and 24 µM, 
respectively. Data are consistent with the proposed ordered kinetic mechanism. 
If the assumption is made that Ki1 = Ki2, perhaps reasonable due to the similarity 
in the structures of the desulfo-CoA to CoA and AcCoA, the amount of E:Hc that 
builds up in the steady state can be estimated. The ratio Ki1/Ki2 is directly proportional 
to the amount of E:Hc that builds up in the steady state. Estimates that are obtained 
from CoA and desulfo-CoA are 2-5% suggesting a significant but small contribution 
of the release of homocitrate to overall rate limitation under Vmax conditions. A 
reasonable kinetic mechanism for HCS under Vmax conditions is given below: 
 
E:α-Kg:AcCoA E:HcCoA E:Hc:CoA E:Hc [12]k5
k6
k7 k9 k11
 
 
where HcCoA is homocitryl-CoA, k5 and k6 represent formation of HcCoA and its 
decomposition to reactants α-Kg and AcCoA, k7 represents hydrolysis of HcCoA to 
products Hc and CoA, and k9 and k11 represents release of CoA and Hc, respectively. 
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 The expression for Vmax is then given below in terms of enzyme forms that build up in 
the steady state. 
 
V = Etk6 + k7
k5k7
+ 1
k7
+ 1
k9
+ 1
k11
= Et
E :α −Kg : AcCoA + E : HcCoA + E :Hc :CoA + E : Hc
[13] 
 
If E:Hc is 2-5% of the total enzyme at saturating substrates, the remaining 95-
98% is made up of some combination of the remaining enzyme forms. The 
determination of distribution will have to await further studies including those using 
isotope effects to probe the chemical steps. 
 
3-4-2. Fluorescence binding studies 
The dissociation constant for the E:α-Kg complex obtained from steady state 
kinetic studies (Kia in Table 3-1) is identical to that obtained from fluorescence 
titration, Table 3-3. However, fluorescence data, Table 3-3, indicate finite binding of 
AcCoA and CoA to free enzyme. The Kd for E:AcCoA (450 µM), Table 3-3, is more 
than 200 times higher than the Km for AcCoA (2 µM), Table 3-1. In addition, the Kd 
for E:CoA, (170 µM), Table 3-3, is almost 100 times higher than its Ki for the E:α-
Kg:CoA complex (1 µM), Table 3-2. It is thus possible that the kinetic mechanism of 
HCS is random with a high degree of synergism of binding between α-Kg and AcCoA 
(There is a similar but less pronounced difference in the dissociation constant for 
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 enzyme-α-Kg complex and its Km). Since the ordered mechanism suggested for HCS 
may arise as a result of a high degree of synergism (13) as described above, we 
suggest a preferred ordered mechanism. Although one would expect NC inhibition by 
CoA vs. α-Kg in this case, the concentration of CoA used in these studies would not 
be sufficient to generate a significant slope effect as a result of CoA binding to E at 
low α-Kg. 
Interestingly, the binding of CoA (in contrast to AcCoA) to the HCS enhances the 
intrinsic fluorescence of the HCS suggesting a conformational change that alters the 
microenvironment of the strategically located single tryptophan residue of the enzyme 
toward an increased hydrophobicity. The reasoning for this phenomenon may be the 
closure of the active site upon binding of the CoA to the free enzyme or E:α-Kg 
complex, consistent with the increased Kd of E:α-Kg:CoA, Table 3-3. 
 
3-4-3. Active site specificity and kinetic mechanism 
Based on the inhibition studies and data obtained with the alternative substrate 
OAA, some information can be provided on the active site of HCS. As shown in Table 
3-3, the dissociation constant (Kd) of E:OAA (3.7 mM) is less than that for E:α-Kg (25 
mM) suggesting that the binding of OAA is favored by about 1.1 kcal/mol. On the 
other hand the second order rate constant (V/KEt) is a factor of 16 higher for α-Kg 
than for OAA. This reflects a kinetic preference for binding of α-Kg of about 1.7 
kcal/mol. (The V/K for the first substrate in an ordered mechanism is its rate constant 
for combination with enzyme. For a simple, single step binding process this rate 
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 constant would be expected to equal the diffusion limit of 108 M-1s-1. The low values 
observed for both substrates suggest a multi-step binding process with the first 
reactant inducing a conformational change in enzyme to facilitate binding of the 
second substrate.) 
The value of Ka/Kia is almost the same for both α-Kg and OAA, and the crossover 
point for the intersecting initial velocity pattern is above the horizontal axis for both 
substrates due to be less than unity of the Ka/Kia ratio. The kinetically determined Kia 
for E:α-Kg is the same as fluorescently determined Kd. However, this is not the case 
for OAA. This discrepancy may be explained by some randomness in the kinetic 
mechanism in which OAA can bind productively to the E:AcCoA complex 
(preliminary data agree with this suggestion). It is also possible that with OAA as a 
substrate, some nonproductive binding is observed. However, in this case a decrease in 
Km and Vmax would be expected for OAA compared to α-Kg and this is not observed. 
The low Kd for OAA binding relative to α-Kg, see above, and inability of the 
enzyme to accommodate the carboxyethyl moiety of the γ-ketopimelate suggests that 
α-Kg, when bound, may be somewhat strained, i.e. it does not bind in an extended 
conformation, and the shorter OAA may fit better in the active site. The fact that 
succinate is not an effective inhibitor suggests that α-carbonyl group is important for 
binding, as expected since the carbonyl oxygen must be protonated as homocitryl CoA 
is formed. In the case of HCS from T. thermophilus, α-ketoadipate and α-
ketoisovalerate have no effect on enzyme activity as reported (10), so that chains 
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 longer than 5 carbons or with bulkier side chains are not accommodated. Additional 
kinetic experiments are required to better understand active site specificity. 
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 CHAPTER 4 
Regulatory mechanism of homocitrate synthase: I. KINETIC 
STUDIES 
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tagged Homocitrate Synthase from Saccharomyces cerevisiae I. KINETIC STUDIES, J. Biol. Chem. 280, 31624-31632] 
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4-1. Introduction 
There are two distinct pathways for the biosynthesis of the essential amino acid 
lysine. The diaminopimelate pathway is common among plants, bacteria and lower 
fungi (Phycomycetes or algal fungi). Homocitrate synthase (HCS) [2-hydroxybutane-
1,2,4-tricarboxylate 2-oxoglutarate-lyase (CoA-acetylating), EC 2.3.3.14] is the first 
and committed enzyme of the α-aminoadipate pathway for the biosynthesis of lysine 
that is unique to higher fungi (Ascomycetes and Basidomycetes). Pathogenic fungi 
such as Candida albicans, Cryptococcus neoformis and Aspergillus fumigatus (human 
pathogens) and Magnaporthe grisea (a plant pathogen) use the α-aminoadipate 
pathway for lysine biosynthesis. The uniqueness of the α-aminoadipate pathway 
makes it a potential target for the design of antifungal drugs to protect 
immunocompromised patients (transplant, AIDS and cancer patients) against 
opportunistic fungi (1–6). 
The α-aminoadipate pathway begins with the condensation of α-ketoglutarate 
with AcCoA to yield homocitrate and coenzyme A (1–6). There are two isozymes of 
homocitrate synthase in Saccharomyces cerevisiae, cytosolic and mitochondrial, and 
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 both isozymes are feedback inhibited by lysine and the expression of the cytosolic 
isozyme is repressed by lysine (7). However, HCS is a physiologically complex 
enzyme, and in addition to its role in lysine biosynthesis, the localization of this 
enzyme in the nucleus (8) and its interaction with a number of nuclear proteins 
(BIND: Biomolecular Interaction Network Database) (www.bind.ca) suggest possible 
additional function in the nucleus and complex regulation. 
There are few studies of the regulation of the HCS. In Saccharomycopsis 
lipolytica it has been shown that the HCS activity is completely inhibited by lysine 
and some lysine analogues like hydroxylysine and diaminopimelic acid (9). In the case 
of the enzyme from Penicillium chrysogenum, the inhibition by lysine was shown to 
be competitive with respect to α-ketoglutarate and pH dependent with only 20% 
inhibition by 1 mM lysine at pH 6.6-7.0 (10). It has been also reported that the HCS 
from Thermus thermophilus is highly sensitive to lysine (11). Regulation of HCS 
activity by CoA and divalent metal ions has also been reported (12). 
In this paper, we make use of steady state kinetic and fluorescence binding studies 
to probe the kinetics of regulation of the cytosolic HCS from Saccharomyces 
cerevisiae. Our data suggest that lysine is a competitive inhibitor and the effects of 
lysine and Na+ are independent of one another in the regulation of HCS. However, 
dependent on the concentration of the modulators and the concentration of substrates, 
the reaction can be either activated or inhibited. In an accompanying article (24), 
theory is developed for regulation by multiple effectors on the basis of studies 
presented in this manuscript. 
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 4-2. Materials and methods 
4-2-1. Materials 
All chemicals were of the highest grade commercially available. α-Ketoglutarate, 
DCPIP, AcCoA, lysine and LiCl were obtained from Sigma. KCl, CsCl, CaCl2 and 
MnCl2 were purchased from Fisher Scientific, while MgCl2 was from FisherBiotech. 
(NH4)2SO4 was from Fluka, and NaCl was from EMD. 
The concentration of AcCoA was adjusted spectrophotometrically (ε260, 16.4 mM-
1cm-1). The AcCoA solution in ddH2O is stable, without any significant hydrolysis, for 
at least one month if kept at -21 °C. The concentration of DCPIP preparations was also 
adjusted spectrophotometrically (ε600 nm, 19.1 mM-1cm-1). 
 
4-2-2. Assays of homocitrate synthase activity 
Cell growth, HCS expression and purification were performed as previously 
described (13). A typical assay for HCS using the DCPIP method is as described with 
slight modifications (13). The final volume of the assay was 0.5 mL and contained 50 
mM Hepes, pH 7.5 (adjusted by KOH), and variable concentrations of α-ketoglutarate 
and AcCoA (~Km–20Km) and 0.1 mM DCPIP. All assays were carried out at 25 °C. 
Reactions were thermally equilibrated to allow for completion of the reaction between 
CoA (in the AcCoA solution) with DCPIP before adding the enzyme to the reaction 
mixture. 
In order to dissolve precipitated α-cyclodextrin in the stabilized HCS suspension 
(due to its interaction with other buffer components) (13) glycerol was added to a final 
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 concentration of 10%. An enzyme solution prepared by this method is stable at room 
temperature for up to three to four hours after which, the enzyme begins to lose 
activity. 
 
4-2-3. Initial velocity studies 
Initial velocity patterns were obtained by measuring the initial rate as a function 
of AcCoA concentration (0.0125-0.125 mM) and a fixed concentration of α-Kg and 
the experiment was then repeated at several additional α-Kg concentrations (1-10 
mM). An additional initial velocity pattern was also repeated using 0.0125-2.0 mM 
AcCoA at fixed concentrations of 0.5-10 mM α-Kg. The above initial velocity pattern 
was then repeated at several different fixed concentrations of the effector (including 
zero). In case of Na+, concentrations of 0, 25, 100 and 250 mM were used, while 
concentrations of 0, 0.25, 0.5 and 1 mM were used for lysine. An initial velocity 
pattern was also repeated using high AcCoA concentration (0.5 mM) and 1-10 mM α-
Kg at several additional lysine concentrations of 0, 0.25, 0.5, 1, 1.5, 2, 3, 4 and 5 mM. 
To study the interaction between Na+ and lysine, the initial rate was measured at a 
fixed concentration of α-Kg (1.46 mM≈0.5 Kα-Kg) and a fixed concentration of AcCoA 
(0.0125 mM≈2 KAcCoA, low, or 0.5 mM≈100 KAcCoA, high) with the lysine 
concentration varied (0-1 mM) at different fixed concentrations of NaCl (0-250 mM). 
 
 
 
100
 4-2-4. Fluorescence binding studies 
Fluorescence spectra were measured as previously described (13). Emission 
spectra (310-400 nm) were measured with the excitation monochromator fixed at 298 
nm. Spectra were recorded on a Shimadzu RF-5301 PC spectrofluorometer equipped 
with a circulating water bath to maintain the temperature at 25°C. Fluorescence quartz 
cuvettes with a volume of 1 mL and a path length of 1 cm were used to measure 
sample and blank spectra. Excitation and emission slit widths were set to 1.5 nm and 5 
nm, respectively. Because all of the reagents and buffer components have no 
absorbance above 310 nm, the inner filter effect is negligible under conditions used for 
taking the spectra. 
The final buffer composition used to measure the spectra contained 55 mM Hepes 
(adjusted to pH 7.5 with KOH), 150 mM (NH4)2SO4, 25 mM guanidinium chloride 
(GdmCl), 25 mM α-cyclodextrin, 8 mM KCl and 5 mM imidazole. All samples 
contained enzyme at a concentration of 55 µg/mL. Compounds used for fluorescence 
studies were α-Kg and lysine that were added sequentially from low to high 
concentration to both the blank and sample from a stock solution of 1 M for α-Kg, 1 
M and 10 mM for lysine. The final total dilution in each case was 1.07 (α-Kg), 1.02 
(10 mM stock solution) and 1.05 (1 M stock solution) (lysine), and all the data were 
corrected for dilution. 
To calculate the Kd based on the fluorescence intensity, data were fitted to the 
equation for a rectangular hyperbola, eq 1: 
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where ∆F is the change in intrinsic tryptophan fluorescence upon addition of ligand to 
enzyme, ∆Fmax is the maximum change in fluorescence at infinite ligand 
concentration, L is the ligand concentration, and Kd is the dissociation constant for the 
enzyme-ligand complex. 
Due to nonlinearity of the lysine fluorescence data, they were fitted to eq 2, which 
represents the sum of two independent saturation curves indicating binding to non-
interacting sites: 
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where L is the lysine concentration, and ∆Fmax1 and ∆Fmax2 are the maximum change 
in fluorescence intensity upon binding of lysine to the first and second binding sites, 
respectively. Kd1 and Kd2 are the dissociation constants associated with the binding of 
lysine to the aforementioned sites. 
 
4-2-5. Effect of monovalent and divalent cations on HCS activity 
Fixed concentration of α-Kg (5 mM≈2Kα-Kg) and either low (0.031 mM≈5KAcCoA) 
or high (0.5 mM≈100KAcCoA) AcCoA concentrations were used at different 
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 concentrations of monovalent and divalent cations (0-250 mM). Li+, Na+, K+, Cs+, 
Mn2+, Mg2+, Ca2+ were used as an additive to test their effects on HCS activity. 
 
4-2-6. Data analysis 
Data were fitted using the appropriate equations and the Marquardt-Levenberg 
algorithm supplied with the EnzFitter program from BIOSOFT, Cambridge, UK 
(www.biosoft.com). Rate, kinetic and dissociation constants and their corresponding 
standard errors were estimated using a simple, proportional or statistical robust 
weighing method (dependent on the maximum change in initial rate or ∆F observed in 
the experiment) for the activity or affinity of the enzyme by fitting the curves to the 
data either in the absence or presence of inhibitors or ligands. Some simple 
simulations for some of the equations were carried out using the MATHEMATICA 
version 5.0.1.0 from Wolfram Research, Inc., IL, USA (www.wolfram.com). 
Derivation of equations and theory are included in the accompanying article (24). 
Data consistent with a sequential kinetic mechanism were fitted to eq 3. 
 
ABAB
AB
+′+′+′= babia
V
KKKK
ν        (3) 
 
In eq 3, ν and V are initial velocity and maximum velocity, A (α-Kg) and B 
(AcCoA) are reactant concentrations, K′a and K′b are Michaelis constants for A and B, 
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 and Kia is the inhibition constant for A (the dissociation constant for EA, since HCS 
has an ordered kinetic mechanism (14)). 
 
4-3. Results 
4-3-1. Initial rate studies of lysine inhibition 
In order to determine what forms of the enzyme bind lysine, the HCS reaction in 
the presence of lysine was treated as a terreactant (three reactants) reaction (15). 
Double reciprocal initial velocity patterns were obtained varying AcCoA at different 
fixed levels of α-Kg and zero lysine. This initial velocity pattern was then repeated at 
different lysine concentrations, Fig. 4-1A-D. The crossover points for all double 
reciprocal plots are to the left of the ordinate. Graphically, secondary plots were 
constructed by plotting the slopes (Fig. 4-2A) or intercepts (Fig. 4-2B) obtained from 
the plots in Fig. 4-1 against the reciprocal of the α-Kg concentration. Note that in Fig. 
4-2A-B, there is no effect of lysine on the intercept of either the slope or intercept 
secondary plots. Finally, tertiary plots were constructed by plotting the slope from 
Figs. 4-2A and 4-2B vs. the concentration of lysine (Fig. 4-2C-D).  Estimates of all of 
the kinetic parameters were obtained by fitting all of the data in Fig. 4-1 to eq 4 (see 
below). We present all of the data in this case, so that the method is clear to the reader; 
and so that it may be adapted to other systems. Kinetic parameters are summarized in 
Table 4-1. Values of Ki α-Kg, Kα-Kg, KAcCoA, and V/Et are within error identical to those 
reported previously (14). 
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 Partial inhibition by lysine was reported for the HCS from Penicillium 
chrysogenum (10). Thus, an initial velocity pattern was obtained at fixed AcCoA (0.5 
mM≈100KAcCoA) varying the concentration of α-Kg at different lysine concentrations 
(up to 5 mM). Data (see Appendix - Fig. A-5) indicates that in case of HCS from S. 
cerevisiae, lysine is a linear inhibitor over this concentration range. It should be also 
noted that initial rate measured for lysine inhibition studies is affected to some extent 
by the independent activatory effects of the monovalent cations present in the enzyme 
stock solution that introduce some (manageable) error in the data analysis. 
 
4-3-2. Initial rate studies of sodium inhibition and activation 
Initial velocity patterns were obtained as in Fig. 4-1, with the exception that Na+ 
replaced lysine (see Appendix – Figs. A-6 and A-7). As for lysine, Na+ does not affect 
the intercept of the secondary replots. Fig. 4-3 shows the tertiary replots of the slope of 
the slope replot (Fig. 4-3A) and the slope of the intercept replot (Fig. 4-3B). At low 
concentrations of both reactants (Fig. 4-3A), Na+ exhibits complex behavior with 
activation at low concentrations and linear inhibition at high concentrations. At high 
AcCoA and low α-Kg, Na+ exhibits only activation. Estimates of kinetic parameters 
are obtained by fitting all of the initial velocity data (see Appendix – Fig. A-6) to eq 5 
(see below), and a summary of the estimates is given in Table 4-1. 
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 4-3-3. Effect of lysine and Na+ 
The behavior of the enzyme in the presence of both Na+ and lysine is shown in 
Figs. 4-4 (low AcCoA) and 4-5 (high AcCoA). The rate in the absence of both Na+ 
and lysine is the frame of reference in these studies. The effect of lysine in the absence 
of Na+ is given at zero Na+, while the effect of Na+ in the absence of lysine is given as 
the intercepts of Figs. 4-4A and 4-5A and these are replotted in Figures 4-4C and 4-
5C. For all conditions the effects of one of the modulators in the absence of the other 
is consistent with data obtained in Figs. 4-1 to 4-3. The interaction between the two 
modulators is given by the slope replots, Figs. 4-4B and 4-5B. The slope is, within 
error, independent of the concentration of Na+ at high AcCoA concentration. 
 
4-3-4. Fluorescence determination of the HCS-ligand dissociation constant 
The binding of lysine to HCS as measured by fluorescence titration is biphasic, 
Fig. 4-6. Data were fitted to eq 2, which describes the sum of the two independent 
binding phenomenons. In addition, the Kd for α-Kg was measured in the absence and 
presence of lysine. Estimates of the Kd values are listed in Table 4-2. 
 
4-3-5. Effect of monovalent and divalent cations on HCS activity 
As shown in Fig. 4-7, monovalent cations activate HCS at low concentration, but 
inhibit at high concentrations when the activity is measured at low AcCoA and α-Kg 
concentrations. Monovalent cations other than Na+ are less inhibitory at higher 
concentrations of AcCoA similar to the effect of Na+ (see above). Among the 
110
 monovalent cations studied smaller cations (Li+, 60 pm; Na+, 95 pm, K+, 133 pm; and 
Cs+, 169 pm) show a greater inhibition and a lower activation. K+ seems to be the best 
cation for HCS activity since it has the lowest inhibitory effect. The effect of NH4+ lie 
between the effects of Li+ and Na+ (data not shown). 
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Table 4-2: Dissociation constants of ligand-HCS complexes by fluorescence titration. 
Ligands Kd (mM) 
α-Ketoglutarate 26.1 ± 1.1 
α-Ketoglutarate (+ 50 mM L-Lys) 34.8 ± 1.2 
L-Lysine 0.04 ± 0.008, 255 ± 70 
 
Of all of the divalent cations studied (Mn2+, 75 pm; Mg2+, 65 pm; and Ca2+, 100 
pm) smaller divalent cations exhibit a higher degree of inhibition, and are inhibitory at 
low AcCoA concentration. Experiments show that Mg2+ is much less inhibitory at 
lower concentration when used at high AcCoA concentration (Fig. 4-7 inset). In 
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Fig. 4-6: Fluorescence titration of HCS with lysine. A plot of ∆F vs. the concentration of lysine is 
biphasic. Data were collected as discussed in Materials and Methods. Points are experimental, 
while the solid curve is theoretical based on a fit of the data to eq 2. 
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 general, it seems that the inhibitory effects of all of the monovalent and divalent 
cations are related to the density of the positive charge on the surface of the ion or 
charge to mass ratio. The cations with more positive charge density show greater 
inhibitory effects on HCS activity. 
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Fig. 4-7: Effect of monovalent and divalent cations on HCS activity at low reactant concentrations.
Conditions were the same as those used in Fig. 4A. The concentration of the monovalent cations is 
as indicated for (◆) KCl, (■) NaCl, (▲) LiCl and (●) CsCl. Inset shows the effect of Mg2+ on HCS 
activity at (◆) low (0.031 mM) and (■) high (0.5 mM) AcCoA concentration. Curves are drawn by 
eye. 
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 4-4. Discussion 
4-4-1. Inhibition by lysine 
An ordered kinetic mechanism has been proposed for the HCS from 
Saccharomyces cerevisiae (14). As a result of the observation of an E:AcCoA 
complex, a possibility was raised that the HCS kinetic mechanism could be steady 
state random, and this will be addressed below under the Na+ effect. The data in Fig. 
4-1, can thus be interpreted in terms of the enzyme forms along the reaction pathway 
in an ordered mechanism. The data in Fig. 4-2 indicate that there is no effect of lysine 
on the intercept of the slope and intercept replots. The intercept of the slope replot 
represents the E:α-Kg form of the enzyme, while the intercept of the intercept replot 
represents whatever enzyme form or forms build up in the steady state with substrates 
at saturating concentration. The slopes of both replots, on the other hand represent free 
enzyme, and both reflect the inhibition by lysine. Thus, lysine binds to free enzyme to 
cause inhibition. 
The overall rate equation for lysine inhibition (up to 5 mM) is given by eq 4, 
where ν and V are initial and maximum rates, the terms representing free enzyme, 
KiaK′b and K′aB (representing free enzyme under the conditions of the assay) are 
multiplied by (1 + Lys/Ki lys), where A and B are α-Kg and AcCoA, and Kia, K′a and 
K′b are Ki α-Kg, Kα-Kg and KAcCoA, respectively. Lys is the concentration of lysine and Ki 
lys is the dissociation constant for the E′lysine complex. 
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A fit of the all data in Fig. 4-1 to eq 4 gives kinetic parameters that are identical to 
those reported previously and a Ki lys for the E′lysine complex of 550 µM. 
Lysine binding to HCS was also measured by fluorescence titration, but a 
difference is obtained in the magnitude of Ki lys, with a value of 550 µM from kinetic 
studies, Table 4-1, and values of 40 µM and 255 mM from fluorescence titration, 
Table 4-2. The value of 255 mM likely reflects a nonspecific binding of some sort. 
The value of 40 µM reflects binding to a site with high affinity, but it is an order of 
magnitude lower than the value obtained from steady state kinetic studies. Quenching 
of HCS intrinsic tryptophan fluorescence by KI, CsCl and acrylamide exhibits 
downward curved Stern-Volmer plots consistent with at least two different 
environments for the single tryptophan in the HCS (13). If lysine binds to only one of 
the conformers, a difference in the Ki lys obtained from steady state studies and the Kd 
from fluorescence titration would be observed. Thus, the apparent competition 
between lysine and α-Kg likely arises from the two ligands binding with high affinity 
to the two different conformers of the enzyme with lysine stabilizing the inactive or 
less active form and α-Kg stabilizing the more active form. As a result Ki lys, reflects 
the E′Lys complex. 
The inhibition by lysine of the HCS from P. chrysogenum was reported to be 
partial (11). However, the inhibition of the HCS from S. cerevisiae by lysine appears 
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 to be linear up to a concentration of 5 mM. The competitive inhibition by lysine vs α-
Kg (at low concentration) is consistent with active site and not allosteric inhibition. 
However, there are several lines of evidence that argue against active site 
combination: 1) Mutant forms of HCS have been isolated that are insensitive to lysine 
feedback inhibition but are quite active (16); 2) α-Ketoglutarate is an α-
ketodicarboxylic acid, while lysine is an α,ε-diamino acid, and their structures are 
inconsistent with direct competition for the same site; 3) The presence of lysine has no 
significant effect on the Kd for E:α-Kg consistent with an allosteric binding site for 
lysine. 
 
4-4-2. The Na+ effect 
As for lysine inhibition, the effect of Na+ is only observed on the secondary 
replots of slope and intercept vs α-Kg. Thus, as for lysine, the Na+ effect is observed 
as a result of binding to free enzyme. Unlike the effect of lysine, however, the effect of 
Na+ differs dependent on the concentration of AcCoA. When AcCoA is high, Na+ is 
an activator, Fig. 4-3B, giving an overall activation of about 4-fold with a Kact of 12 
mM. At low AcCoA, the effect of Na+ is more complex. It is still an activator at low 
concentrations, but is a linear inhibitor at higher concentrations with a Ki Na of 37 mM 
(from graphical analysis). At low AcCoA, the predominant form of the enzyme is E, 
but as its concentration approaches and exceeds the Kd for E:AcCoA (450 µM), 
E:AcCoA will predominate. The tertiary plot shown in Fig. 4-3B represents the limit 
where AcCoA is increased to infinite concentration and α-Kg is near zero 
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 concentration. As a result all of the enzyme should be in the E:AcCoA form. Thus, 
inhibition likely occurs as a result of Na+ binding to the AcCoA site, while activation 
occurs in the free enzyme form, likely as a result of binding to a site other than the 
active site. We suggest the combination is not to the active site as a result of the 
dianionic nature of α-Kg which apparently competes with Na+ (the Na+ effect is 
eliminated at saturating α-Kg). 
The above discussion assumes the presence of an E:AcCoA complex. To probe 
the kinetic significance of the E:AcCoA complex, an initial velocity pattern was 
carried out with AcCoA varied over a wider range (12.5 µM to 2 mM) compared to 
that used in the previous study (12.5 µM to 125 µM) (14). The initial velocity pattern 
is shown in Fig. 4-8, and indicates competitive substrate inhibition by AcCoA vs α-
Kg. Data thus indicate an ordered mechanism with formation of a dead-end E:AcCoA 
complex. Thus, α-Kg can not bind to E:AcCoA to give a productive E:AcCoA:α-Kg 
complex. The KIb for substrate inhibition by AcCoA is 0.93 ± 0.16 mM, similar to the 
value of about 0.45 mM obtained from fluorescence titration (14), especially given the 
standard error on KIb. An equation derived based on the above logic and Scheme 4-1 is 
given in eq 5, which includes Na+ inhibition. 
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 In eq 5, A, B, and Na are α-Kg, AcCoA, and Na+ concentration, respectively, 
while Kia, K′a, K′b, Ki Na and Kact are the dissociation constant for α-Kg, the Michaelis 
constants for α-Kg and AcCoA, the inhibition and activation constants for Na+, 
respectively. Kconf and K′conf are equilibrium constants for the conformation change in 
E in the absence and presence of Na+, respectively, which is E′/E, where E′ is the less 
active form. Equation 5, as written, did not give reasonable estimates of the kinetic 
parameters, unless K′conf was set equal to zero. It thus appears that E′Na and ENa 
interconversion (Scheme 4-1) is very slow relative to enzymatic activity time scale 
(K′conf can still be considered as equal to Kconf). Although a thermodynamically 
balanced model requires that Kconf = K′conf = 3, the value of K′conf is considered zero 
due to a slow interconversion. Therefore, from the point of view of the kinetic time 
scale, Na+ does not bind to the inactive or less active form of the enzyme. 
 
4-4-3. Interaction of Na+ and lysine 
Data obtained varying the concentrations of Na+ and lysine indicate that Na+ 
activates the HCS at any lysine concentration; therefore, Na+ can bind to the E′Lys 
complex (see above) to form E′LysNa. The Kact values for Na+ for both E and E′Lys 
(low AcCoA) are identical within error (Table 4-1). Equation 6 can be used to describe 
the enzymatic behavior of HCS in the presence of both Na+ and lysine as represented 
in Scheme 4-2 with the assumption that K′conf = 0 and Kconf = 3 (see above). A fit of 
the data to eq 6 shows that Kact = K″act at either low or high AcCoA (Table 4-1) 
indicating that Na+ binds with equal affinity in the absence or presence of lysine (as 
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 represented by Kact and K″act) to the E and E′ forms of the enzyme. As suggested in 
Scheme 4-2, there is no evidence that lysine can bind to the E (active form) form of 
the enzyme. 
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In eq 6, Na, Lys, Ki Na and Ki lys are the concentrations of Na+ and lysine, and 
inhibition constants for Na+ bound to E and lysine bound to E′, respectively. Kact and 
K″act are the activation constant for Na+ for the active and lysine-bound less active 
forms of the enzymes. kp is the overall enzymatic rate in the absence of inhibitor and 
E′Lys E′
ENa
E
E′NaE′LysNa
Lys/Ki lys Na/Ki
Na/KactNa/K′actNa/K"act
Kconf
K′conf
P
kp
kp
Lys/Ki lys Na/Ki NaENa
NaE
Na/Kact
Scheme 4-2: Kinetic mechanism for interactive Na+ and lysine effects. Na, E, and E′ represent Na+, 
active, and less active forms of the enzyme, respectively. Kconf  and K′conf are the equilibrium 
constant between the free active and less active and Na+-bound active and less active forms of the 
enzyme. Kact, K′act and K″act are the activation constants of the Na+ for active and less active and 
lysine-bound less active forms of the enzyme. Ki lys is the inhibition constant for lysine. 
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 activators. As shown in Table 4-1, the presence of lysine does not significantly change 
the values of kinetic parameters (Kact and Ki Na) for Na+ at low AcCoA. The presence 
of high AcCoA increases the values of kinetic parameters by a factor of 2–5 consistent 
with the second substrate forcing the enzyme into the E:AcCoA form, which is 
apparently less active as compared to E. Thus, Na and or α-Kg are required to 
generate the E form of the enzyme. Simulations carried out in the accompanying 
article (24) using eq 6, provide more detailed information concerning the behavior of 
HCS in the presence of both lysine and Na+. The overall regulation of HCS by Na+ 
and lysine is illustratively shown in Fig. A-17 (see Appendix). 
 
4-4-4. Effect of other monovalent cations and divalent cations on HCS 
activity 
In general the mode of action of monovalent cations on enzyme activity is poorly 
defined. Two types of mechanism have been proposed to explain the effects of metal 
ion on catalytic activity (17–18). In the first mechanism, metal ion has a static 
structural role that activates the enzyme by stabilizing the catalytically active 
conformation of the enzyme. The second mechanism proposes a dynamic role for the 
metal ion that selectively assists the enzyme in specific conformational transitions 
essential to catalysis. Both mechanisms could be involved in the activation of HCS by 
cations with the first mechanism being more likely, but this aspect will require 
additional study. 
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 4-4-5. Physiologic significance 
The measured intracellular concentrations of α-Kg, AcCoA, lysine and Na+ plus 
K+ are 3, 0.3, 5 and 150 mM, respectively (19–23). On this basis, it appears that HCS 
is inhibited by lysine under physiological conditions. On the basis of the value for Ki 
lys and the concentration of lysine inside the cell, the fraction of active HCS is almost 
10% of the total enzyme and the enzyme is present as the E′Lys complex. Saturating 
levels (for HCS) of AcCoA in the cell diminish the inhibitory effects of Na+ while 
maintaining its activatory effect. As shown in Fig. 4-3B, the increase in activity by 
Na+ at high AcCoA is almost 3–4 fold. Therefore, the net active enzyme is equivalent 
to about 40%. However, as shown in Table 4-1, the physiological concentration of 
monovalent cations (150 mM) is the same as its Ki Na value at high AcCoA giving an 
almost 50% decrease in HCS activity. Therefore, the net activity of HCS is 20%. It has 
been reported that variation in the α-Kg pool is responsible for changing flux through 
the lysine pathway (23). Since the concentration of α-Kg is around its Km, it is the 
main determinant for the flux through the lysine biosynthetic pathway (23). The 
kinetic data reported in this study are consistent with this hypothesis. Although, 
variation in the concentrations of AcCoA and lysine are important to the flux through 
HCS, the reported data (20) generally indicate that variations in the concentrations of 
AcCoA and lysine (with respect to their kinetic parameters) are negligible for the HCS 
suggesting no significant effects on HCS activity by these modulators. Therefore, 
choosing strains containing HCS mutants insensitive to lysine inhibition are one of the 
several options required to increase the production of lysine at a commercial level. 
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 Also, in the area of enzyme inhibitor design, theoretically, the most efficient inhibitors 
for HCS under physiological conditions, would be those that bind with high affinity to 
the α-Kg binding site. 
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 CHAPTER 5 
Regulatory mechanism of homocitrate synthase: II. THEORY 
 
 
“Reproduced with automatic permission from [Andi, B., and Cook, P. F. (2005) Regulatory Mechanism of Histidine-tagged 
Homocitrate Synthase from Saccharomyces cerevisiae I. THEORY, J. Biol. Chem. 280, 31633-31640] Copyright [2005] The 
American Society for Biochemistry and Molecular Biology, Inc.” 
 
5-1. Introduction 
Homocitrate synthase (HCS) [2-hydroxybutane-1,2,4-tricarboxylate 2-
oxoglutarate-lyase (CoA-acetylating), EC 2.3.3.14] catalyzes the first and committed 
reaction in the α-aminoadipate pathway for the biosynthesis of lysine that is unique to 
higher fungi (1–4). Both cytosolic and mitochondrial isozymes of the HCS from 
Saccharomyces cerevisiae are feedback inhibited by lysine (5). It has also been 
reported that HCS activity can be affected by the presence of CoA and divalent metal 
ions (6). 
In this paper, rate equations are derived to predict the regulatory effects of Na+ 
and lysine on the activity of HCS, on the basis of experimental data presented in the 
accompanying article (11). Rate equations were derived using the King-Altman 
algorithm method (7) and Cha’s rapid equilibrium assumption (8). The simulated data 
correlate well within error, with the experimental data and suggest that the activity of 
the HCS in the presence of Na+ is simultaneously inhibited and activated. In the 
presence of lysine and Na+, the kinetic behavior of HCS is complex, and the Na+ effect 
is independent of lysine. 
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 5-2. Materials and methods 
5-2-1. Data analysis and simulation 
Kinetic parameters used for simulation of kinetic behavior were obtained by 
fitting the experimental data presented in the previous article (11) using the 
appropriate rate equations and the Marquardt-Levenberg algorithm supplied with the 
EnzFitter program from BIOSOFT, Cambridge, UK (www.biosoft.com). All of the 
simulations were carried out using the appropriate derived equation and 
MATHEMATICA version 5.0.1.0 from Wolfram Research, Inc., IL, USA 
(www.wolfram.com). 
 
5-3. Theory 
On the basis of the experimental data presented in the accompanying article (11), 
a schematic of the regulatory kinetic mechanism of the HCS by Na+ is shown in 
Scheme 5-1. The model is general in that it allows for binding of effector to all 
enzyme forms. As previously described a conformational equilibrium exists for HCS 
in the absence of reactants (9). The activation, affected by the cations, can be 
explained by stabilizing the E (active) form of HCS. In the case of HCS, Scheme 5-1 
is reduced to a consideration of effector stabilizing only the E form, with no effect 
observed as reactants bind (see accompanying article (11)). The active form of the free 
enzyme is also subject to inhibition by the same effector that activates the enzyme. 
This phenomenon is separate from activation. 
130
 In deriving the equation, all steps for binding of Na+ and the enzyme 
conformational change were assumed to be at equilibrium as shown in Scheme 5-1 
and the mechanism is simplified as at the bottom of Scheme 1 (8). The simplified 
scheme was then used to derive the rate equation by the King-Altman method (7). 
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 The fractions of productive enzyme, i.e., enzyme forms that go on to give product, 
at equilibrium within X are given as follows. Productive enzyme fractions are defined 
as 
X
EfEAB
AB=  and 
X
Ef actEAB
NaAB= , where 
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Substitution for each of the enzyme forms in eq 2 with the parameters defined 
above gives eq 3. 
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Eq 3 can be rearranged as shown in eq 4. 
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 All of the other fractions (fJ) can be defined in the same way for Y and Z, Scheme 
5-1. Therefore, the ENaPQ to EPQ and ENaQ to EQ equilibria are included in Y and 
Z, respectively. However, as long as the affinity for effector is independent of bound 
reactants, 
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for Et (total enzyme) is equal to the sum of all enzyme forms, i. e. X, Y and Z, and this 
gives the denominator of the final rate equation. X, Y, Z and v (the initial rate) can be 
defined as follows, where ∆ is the sum of all of the numerator terms in X, Y and Z. 
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Substitution of the expression for ∆ in eq 9 gives 
 



 +







 +


′



 +


′+


 +


′



 +


′+



 +


′



 +


′



 +


′



 +


′



 +


′
=
act
11
act
115
act
9
act
95
act
5
EAB
11
act
119
act
9
t11
act
119
act
95
act
5
1
f
E
ν
K
k
K
kk
K
kk
K
kk
K
k
k
K
kk
K
k
k
K
kk
K
kk
K
k
5
NaNaNaNaNa
NaNa
NaNaNa
(10) 
 
Substitution of the expression for fEAB into the eq 10 gives 
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In equation 11, if kj = k'j (microscopic rate constants for binding and catalytic 
steps), as is true for Na+ activation of HCS, then the equation reduces to eq 12 after 
rearrangement. 
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 The mechanism in the absence of Na+ is sequential ordered (10). Thus, 
expressions for kinetic parameters can be generated from eq 12 at the limit where Na 
= 0, shown in eq 13. 
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Dividing the numerator and denominator of eq 13 by coefficient AB gives eq 14. 
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 for EAB, and Kia and Kib are the dissociaton constants of A and B for EA and EB, 
respectively. The limit of eq 14 where A and B tend to infinity gives V as 
t
1191159
1195 E



++ kkkkkk
kkk
5
, while the limit where A tends to infinity and B tends to zero 
gives B



′b
V
K
, the limit where B tends to infinity and A tends to zero gives 
A



+



′ confa 1
1V
KK
, and the limit when A and B tend to zero gives 
AB



+



′ confbia 1
1V
KKK
. 
Substituting the above kinetic parameters into eqs 14 and 12 gives the eqs 15 and 
16, respectively (eq 15 is basically equal to eq 16 with Na = 0). 
 
( ) ( ) ABAB
AB
+′++′++′= bconfaconfbia 11
Vν
KKKKKK
     (15) 
 
( ) ( )
( ) ( ) ( ) 


 ++′+





′+++′+










 ++


′+++′



 +
=
act
b
act
confconfa
iactact
confconfbia
act
111
111
1V
ν
K
K
K
KKK
KKK
KKKK
K
NaABABNa
NaNaNa
ABNa
  (16) 
 
139
 In eq 16, for HCS, Kia, K′a and K′b are the dissociation constant for α-Kg and the 
Michaelis constants for α-Kg and AcCoA, respectively, A and B represent the 
concentrations of α-Kg and AcCoA. Kact, K'conf and Ki reflect the activation constant 
for Na+, the conformational equilibrium between E and E′ in the presence of Na+, and 
the inhibition constant for Na+, respectively. Kconf is the equilibrium constant between 
E and E′ in the absence of Na+. Na is Na+ concentration. Table 5-1 gives the limits of 
equation 16. 
In the presence of both lysine and Na+ the behavior of the enzyme is more 
complicated due to the simultaneous activation and inhibition effects of Na+ and 
inhibition by lysine. The kinetic mechanism in this case is shown in Scheme 5-2. 
However, there is no experimental evidence to suggest that any lysine-bound E form 
of the enzyme can be formed (see accompanying article (11)). In this case, all of the 
enzyme species shown are assumed to be at equilibrium, and the rate of the enzymatic 
reaction depicted in Scheme 5-2 is represented as v = kp[(E+ENa)/Et]. kp is the overall 
enzymatic rate in the absence of inhibitors (not V since A and B are maintained at a 
fixed, low concentration), and activators. Et is the sum of all enzyme species that are 
in equilibrium. The rate equation for prediction of the enzymatic behavior (derived as 
above) in this case is as follows: 
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 where K″act is the activation constant of Na+ for the E′Lys enzyme complex. When Na 
and Lys are at zero concentration, v is equal to kp/(1+Kconf). 
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5-4. Results and discussion 
The effect of Na+ on HCS activity is complex with activation and inhibition 
occurring simultaneously dependent on the concentration of Na+. As shown in the 
accompanying article (11), the inhibitory effect is independent of its activation, and 
results from combination at the active site, competing with AcCoA. Graphically, the 
effects of Na+ are observed in the tertiary replots of the initial rate data varying α-Kg, 
AcCoA and Na+. 
The double reciprocal plot of eq 16 with AcCoA varied at fixed levels of α-Kg is 
given in eq 18. 
 
E′Lys E′
ENa
E
E′NaE′LysNa
Lys/Ki lys Na/Ki
Na/KactNa/K′actNa/K"act
Kconf
K′conf
P
kp
kp
Lys/Ki lys Na/Ki NaENa
NaE
Na/Kact
Scheme 5-2: Kinetic mechanism for interaction between Na+ and lysine. Na, E, and E′ represent 
Na+, and the active and less active forms of the enzyme, respectively. Kconf  and K′conf defined in the 
legend to Scheme 1. Kact and K′act are defined in the legend to Scheme 5-1, while K″act is the 
activation constant for Na+ for E′ with lysine-bound. Ki lys and Ki are the inhibition constants for 
lysine and Na+. 
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On the basis of eq 18, expressions for slope and intercept are given in eqs 19 and 
20. 
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If K′conf is equal to zero as found experimentally for HCS, then on the basis of eqs 
19 and 20, expressions for SOS and SOI are given in eqs 21 and 22. Tertiary replots 
are given by the slope of the secondary plot (slope vs 1/α-Kg) or SOS vs Na+ (eq 21) 
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 and the intercept of the secondary plot (intercept vs 1/α-Kg) or SOI vs Na+ (eq 22) and 
are shown in Figs. 5-1 and 5-2. 
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The SOS/SOI ratio is given by eq 23, and is equal to the effective Ki for Na+ at the 
AcCoA site. 
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As shown in Figures 5-1 and 5-2, the y-intercepts (y1) represent SOS and SOI at 
zero NaCl, respectively, given by ( )confbiaSOS-1 1Vy K
KK +

 ′=  and 
( )confaSOI-1 1Vy K
K +′= .
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Fig. 5-1: Tertiary replot of slope of slope for the inhibition and activation by Na+. x2 and x3
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x and y are defined in the text. 
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 The point marked x2 in the SOS and SOI tertiary replots is equal to Kact, i.e. the 
concentration of Na+ that gives half maximal activation in the absence of Na+ 
inhibition. In Fig. 5-1, y2 is the maximal activity for the enzyme, in the absence of Na+ 
inhibition. The value of y2 is 

 ′
V
bia KK  (obtained from the y-intercept of eq 21 when 
Na tends to infinity in the absence of Na+ inhibition). 
The value of y2 in the slope of intercept (SOI) plot is K′a/V (Fig. 5-2), obtained 
from eq 22 at infinite Na. In both SOS and SOI plots, the ratio of y1/y2 is 1+Kconf (the 
fraction of activated enzyme). In Fig. 5-1, x3 is -Ki for Na+ inhibition for the fully 
activated enzyme. If Ki goes to infinity (high AcCoA) then the value of x1 (obtained 
using the derivative of eq 21) in Fig. 5-1, eq 24, is comparable to the value of x1 in 
Fig. 5-2, eq 25, where x1 is an apparent Kact value that depends on the values of Kconf 
and Ki. In other words, it determines the intrinsic effects of Na+ inhibition and 
conformational changes on the Kact value. In the case of HCS the effect is negligible. If 
Kact goes to infinity and Kconf goes to zero, then the value of eq 24 is –Ki. 
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 As Na goes to infinity in eq 21, the equation will reduce to 


 +

 ′
i
bia 1
V K
KK Na , 
which is the equation for the dotted line that extrapolates to x3 as SOS goes to zero. If 
there is no activation by Na+, eq 21 is equal to ( ) 





++

 ′
i
conf
bia 1
V K
K
KK Na . In this 
case, the experimentally measured Ki is equal to ( )confi 1 KK + . Between the two 
extremes, no activation as a result of an infinite Kact and completely activated enzyme 
as a result of infinite Na+, a series of parallel lines is obtained for a plot of SOS vs 
Na+, at constant Ki. The y-intercept depends on the value of Kconf. As the Ki for 
inhibition becomes greater than the Kact for activation by Na+, then the SOS plot (Fig. 
5-1) will show a lower minimum value, indicating a greater observed activation, and 
the linear part of the curve will have a greater slope as Na is increased. 
Data simulation using the experimentally measured kinetic parameters (see 
accompanying article (11)) shows the dependence of activation on the Kact. If the Kact 
for Na+ is much greater than Ki (37 mM), then as described in eq 21, the SOS vs Na+ 
will approach linearity (Fig. 5-3A). If Ki increases, the plot shows less and less 
inhibition, Fig. 5-3B. A 3D plot of the above is shown in Fig. 5-3C. 
The slope of intercept (SOI) (Fig. 5-4) represents a measure of enzyme activity at 
high AcCoA and low α-Kg, and exhibits no inhibition by Na+. In other words, an 
infinite concentration of AcCoA eliminates the Na+ inhibition by increasing its Ki to 
infinity. The percentage of the HCS enzymatic activity vs Na+ based on the derived 
equations, is in a very good agreement with the experimental data (see accompanying 
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 article (11)) indicating that the equations precisely predict the enzymatic behavior of 
HCS at different Na+ concentrations, Fig. 5. Calculation of the percentage of the HCS 
activity is derived by dividing eq 16 by eq 16 when Na = 0 with the assumption that 
K′conf = 0 and is shown in eq 26: 
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As shown in Figures 5-5A and 5-5C, increasing the α-Kg concentration decreases 
both activatory and inhibitory effects at all levels of Na+. Interestingly, the common 
point for all of the curves in Fig. 5-5C is 150 mM Na+, where the HCS activity 
remains at 100%, and this has physiological significance (see accompanying article 
(11)). In terms of equation 26, increasing the level of substrate A gives 100% activity. 
However, increasing AcCoA concentration (B goes to infinity) only eliminates the 
inhibitory effects of Na+, while it has no effect on the activation by Na+, Figs. 5-5B 
and 5-5D. The same mechanism can also be used to explain the behavior of other 
monovalent or divalent cations (see accompanying article (11)). 
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Fig. 5-4: Predicted slope of intercept (SOI) replot for Na+ activation and inhibition as a function 
of NaCl and Kact. Prediction is shown at three different Kact values as recorded on the plot. At 
lower Kact values enzyme reaches the peak activity at lower Na+ concentrations. 
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 The effects of lysine and Na+, in the absence and presence of AcCoA is complex 
(see accompanying article (11)). The equation predicting enzyme activity in this case 
is as follows with the assumption that K′conf = 0 (see accompanying article (11)): 
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where Na, Lys, Ki and Ki lys are the concentrations of Na+, lysine, and inhibition 
constants for Na+ and lysine, respectively. ( )conf
p
1 K
k
+  is the overall enzymatic rate in 
the absence of inhibitors, activators, and a fixed concentration of α-Kg and AcCoA. 
The slope of the above equation when 1/v is plotted vs lysine concentration represents 
the enzyme activity as lysine tends to infinity. This equation can be used to explain 
HCS behavior in the presence of Na+ and lysine at both low and high AcCoA 
concentrations. However, the Ki and Kact values differ at high and low AcCoA. As 
shown in Fig. 5-6, the slope of equation 27 vs Na+ can be concave upward or 
downward depending on the values of Kact and K"act. However, the values of Kact and 
K″act affects the slope in opposite directions, and concentrations higher than 150 mM 
Na+ (in the case of HCS), have almost no effect on the slope either at low or high 
AcCoA. As mentioned above, this phenomenon is thought to have physiological 
significance (see accompanying article (11)). 
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 Fig. 5-7, shows the intercept of equation 27, i.e., when lysine concentration is 
zero. In this case, the equation reflects the kinetic behavior of the enzyme in the 
presence of Na+ as expected and the intercept effect depends on the values of Kact and 
Ki. Increasing the Kact value eliminates the Na+ activation only and has little effect on 
the intercept values (low or high AcCoA), Fig. 5-7A. However, changing the Ki value 
dramatically changes the intercept (low and high AcCoA). Na+ inhibition is eliminated 
at higher Ki values, while activation remains. 
In conclusion, regulatory kinetic behavior of homocitrate synthase demonstrates 
the effect of a bifunctional activatory-inhibitory effector. In this context, the enzyme 
simultaneously senses the activatory and inhibitory effects of the effector and net 
catalytic outcome depends on the concentration of the effector and the activation and 
inhibition constants. The resulting expressions can be applied to enzyme systems that 
exhibit activation and inhibition as a result of interaction at different sites in free 
enzyme. 
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 CHAPTER 6 
Crystal structure of saccharopine reductase at 1.7 Å resolution* 
 
 
“Reproduced with automatic permission from [Andi, B., Cook, P. F. and West A. H. (2005) Crystal Structure of the Histidine-
tagged Saccharopine reductase from Saccharomyces cerevisiae at 1.7 Å Resolution, Cell Biochem. Biophys., In press] Copyright 
[2005] Humana Press, Inc.” 
 
6-1. Introduction 
The budding yeast, Saccharomyces cerevisiae, as well as some human pathogenic 
fungi such as Candida albicans, Cryptococcus neoformans and Aspergillus fumigatus, 
and plant pathogens like Magnaporthe grisea use the α-aminoadipate pathway for the 
biosynthesis of lysine (1). The human pathogens represent a major health threat for 
immunocompromised patients (cancer, transplant, and AIDS patients). In addition, M. 
grisea is among the most destructive pathogens in crop plants (rice blast) (2). The 
uniqueness of the α-aminoadipate pathway in fungal organisms thus makes it a 
potential target for the design of new antimycotic agents (3). 
Saccharopine dehydrogenase (L-Glu forming) (SDH) or saccharopine reductase 
(SR), [N6-(L-1,3-dicarboxypropyl)-L-lysine:NADP+ oxidoreductase (L-glutamate-
forming) (E.C. 1.5.1.10)] catalyzes the penultimate reaction in the α-aminoadipate 
pathway, the reversible condensation of α-aminoadipate-δ-semialdehyde with L-
glutamate and reduction by NADPH to give saccharopine (4-7). 
The SR from S. cerevisiae consists of 446 amino acids with a calculated 
molecular weight of 48,917 (Saccharomyces Genome Database-
*The atomic coordinates have been deposited in the Protein Data Bank (PDB) with the accession code 
2AXQ for the apo enzyme in the space group P3121. 
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 www.yeastgenome.org). An apparent molecular weight of 67,000 has been reported 
using gel filtration chromatography (8), which is close to the value of 73,000 reported 
using sucrose density gradient centrifugation (9). Studies suggest a dimeric solution 
structure for fungal SRs with a molecular mass in the range of 70,000-90,000 (3, 10). 
The saccharopine reductase from M. grisea is 63% identical and 78% similar to 
the enzyme from S. cerevisiae in terms of sequence conservation. The crystal structure 
of the saccharopine reductase from M. grisea was recently solved (3, 11). The 
polypeptide chain of the saccharopine reductase from M. grisea folds into three 
domains. The first domain is a variant of the dinucleotide-binding domain known as a 
Rossmann fold (12) that binds to NADP+ and NADPH. The second domain is an α/β 
fold known as a saccharopine reductase fold (13). The third domain is an all-helical 
domain that apparently moves upon binding of the substrates (3). The SR from M. 
grisea is reported to be a homodimer based on gel filtration and crystal structure (3, 
11). 
In this study, we report the crystal structure of the apo-histidine-tagged 
saccharopine reductase from S. cerevisiae. A comparative structural analysis with an 
emphasis on the active site is presented. 
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 6-2. Materials and methods 
6-2-1. Materials 
All chemicals were of the highest grade commercially available. Ampicillin, 
isopropyl-β-D-1-thiogalactopyranoside (IPTG), KCl, (NH4)2SO4, and Coomassie 
Brilliant Blue G-250 were purchased from Amresco, Gold BioTechnology, Fisher, 
EMD, and BIO-RAD, respectively. Chloramphenicol, phenylmethylsulfonyl fluoride 
(PMSF), NAD+, and saccharopine were obtained from Sigma. Tris-HCl and imidazole 
were purchased from Research Organics. Restriction enzymes were purchased from 
Invitrogen. 
 
6-2-2. Construction of the saccharopine reductase expression plasmid 
To amplify the LYS9 gene (encoding the SR from S. cerevisiae), polymerase chain 
reaction (PCR) was performed on S. cerevisiae genomic DNA (200 ng) using 
Platinum Pfx DNA polymerase purchased from Invitrogen (see Appendix – Fig. A-
8). The following primers (Invitrogen) were used for PCR: 5′-CGT ATT ATA TAT 
TTT CAT ATG GGA AAG AAC G-3′ (forward primer) and 5′-GCG TTC TCG AGT 
TCT TCT TAT TTA AGC CAC TGT C-3′ (reverse primer). The forward and reverse 
primers contain the restriction endonuclease sites for Nde I and Xho I, respectively 
(underlined). The blunt-end PCR product was then ligated into the Sma I linearized 
pUC12 plasmid (see Appendix – Fig. A-9) to produce the pUC12-LYS9 cloning vector 
(see Appendix – Fig. A-10) with which competent DH5α Escherichia coli cells were 
transformed by a 30 second heat shock at 42 °C. The vector was purified from the 
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 DH5α E. coli cells, digested with the restriction enzymes Nde I and Xho I and the 
LYS9 fragment was gel-purified using the GENECLEAN Turbo DNA purification kit 
purchased from QBIOgene. The Nde I and Xho I excised LYS9 fragment was then 
ligated into the pET-16b vector from Novagen cut with the same restriction enzymes 
(see Appendix – Fig. A-11). The host cells used for expression of SR from the pET-
16b-LYS9 expression vector were BL21-Star(DE3)-RIL from Stratagene. The LYS9 
gene of the expression vector was checked for accuracy by DNA sequencing 
(Microgen, University of Oklahoma Health Sciences Center) (see Appendix – Fig. A-
12). 
 
6-2-3. Expression and purification of saccharopine reductase 
The BL21-Star(DE3)-RIL cells containing the pET-16b-LYS9 plasmid were 
grown at 30 °C in 1 L LB medium containing 100 µg/mL ampicillin and 25 µg/mL 
chloramphenicol. The expression of N-terminal (His)10-tagged recombinant SR was 
induced by adding 1 mM isopropyl-β-D-1-thiogalactopyranoside (IPTG) at an OD600 
nm of 0.7-0.9 and incubation continued for an additional 4 hrs with shaking. The 
harvested cells were then suspended in 100 mM Tris-HCl pH 8.0 containing 300 mM 
KCl and disrupted using either sonication (4 × 15 sec. pulse-on followed by 4 × 30 
sec. pulse-off intervals) or French press (800 psi). Because the SR protein is sensitive 
to proteases, 1 mM phenylmethylsulfonyl fluoride (PMSF) was added to the 
suspended cells prior to cell lysis. After removing cell debris by centrifugation at 
12,000g for 10 min, the supernatant was applied to a Ni-NTA column (Qiagen) and 
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 eluted using a linear imidazole gradient of 30-180 mM dissolved in the sonication 
buffer. The purity of the protein was monitored using SDS-PAGE with the gel stained 
with Coomassie Brilliant Blue G-250. 
 
6-2-4. Enzyme assay 
Enzyme assays were performed spectrophotometrically at 25 °C by following the 
reduction of NAD+ (substituted for NADP+) (14) and measuring the increase of 
absorbance at 340 nm (ε340 nm 6.22 mM-1cm-1) using a Beckman DU-640 
spectrophotometer. The reaction mixture contained 100 mM Tris buffer (pH 9.0), 3 
mM saccharopine, and 0.2 mM NAD+ in a 1 mL quartz cuvette. One unit (U) of SR 
enzyme activity is equivalent to one µmole of product (in this case NADH) formed per 
min (at pH 9.0, 25 °C). 
 
6-2-5. Protein crystallization 
Crystal Screen kit and Crystal Screen 2 kit from Hampton Research were used for 
initial crystallization trials using the hanging-drop vapor diffusion method. The 
following home-made screening kits were also used to explore a range of precipitants 
and buffer pH: 1) A range of 6-18% PEG 4000 vs pH (50 mM buffer solutions: 
sodium citrate pH 3.0, sodium acetate pH 5.0, imidazole pH 7.0, sodium borate pH 
9.0), 2) A range of 2.2-2.6 M ammonium sulfate vs pH (50 mM buffer solutions: 
sodium citrate pH 3.0, sodium formate pH 4.0, sodium acetate pH 5.0, Bis-Tris pH 
6.0, imidazole pH 7.0, Tris-HCl pH 8.0, sodium borate pH 9.0) and 3) A range of 2.3-
162
 2.6 M ammonium sulfate vs pH (100 mM buffer solutions: Bis-Tris pH 6.5, Tris-HCl 
pH 7.0, Tris-HCl pH 7.5, Tris-HCl pH 8.0, Tris-HCl pH 8.5, Tris-HCl pH 9.0). 
Crystallization trials were performed by mixing 2 µL of the enzyme solution (13-14 
mg/mL in 100 mM Tris-HCl pH 8.0, 300 mM KCl, and 150 mM imidazole) with the 
same amount of reservoir (precipitant) solution equilibrated over 1 mL reservoir 
solution at 25 °C using 24 well-VDX plates (Hampton Research). 
 
6-2-6. Data collection and processing 
For data collection, crystals were flash-frozen in a stream of nitrogen gas at a 
temperature of 100 K (Oxford Series 700 cryosystem) in mother liquor containing 
10% glycerol as a cryoprotectant. X-ray diffraction data were collected using CuKα 
radiation (λ = 1.5418 Å) produced from a Rigaku/MSC RU-H3R rotating anode X-ray 
generator operated at 50 kV/100 mA and R-Axis IV++ image plate detectors. The 
crystal to detector distance was set at 120 mm, and 303 frames of data (see Appendix 
– Fig. A-16) were collected using an oscillation angle of 0.5°. The exposure time was 
set to 5 min per image. All data were processed with the d*TREK data processing 
package (version 9.2D) (15). 
 
6-2-7. Molecular replacement, model building, structure refinement and 
validation 
The software program Phaser (version 1.3.1) was used for molecular replacement 
using maximum-likelihood techniques (16-18). The candidate model for molecular 
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 replacement was the apo-saccharopine reductase from M. grisea (PDB code: 1E5L) in 
monomer form with side chains removed. For the P31 and P32 space groups, two 
copies of the candidate model were searched as a single component of the asymmetric 
unit such that the output is a dimer. However, only one copy of the candidate model 
was searched as a single component of the asymmetric unit for the P3121 and P3221 
space groups. A medium-range resolution dataset of 8.0-3.0 Å was used for both 
rotation and translation searches using the fast rotation function (FRF) and fast 
translation function (FTF), respectively. The Euler angles for the solutions output from 
the rotation function were automatically input into the Phaser module for the 
translation search. 
Automated model building was carried out using ARP/wARP (19, 20) (version 
6.1) starting from the model obtained from molecular replacement. The initial model 
was refined by ten cycles of auto-building along with five refinement sub-cycles (total 
50 cycles) of REFMAC (21) (version 5.0) using the CCP4 program suite (version 
5.0.1) (22). After removing the residues outside the main domains of the protein, 
manual model building was performed for missing residues using XtalView/Xfit 
software (version 4.1) (23), followed by 20 cycles of maximum-likelihood refinement 
using REFMAC. The ARP/wARP program was used to add solvent atoms. The quality 
of the structure factor data and stereochemical properties of the final model were 
checked using the SFCHECK (24) and PROCHECK (25) programs implemented in 
the CCP4 program suite (22). 
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 6-2-8. Molecular graphics 
All of the figures in this paper were prepared and rendered using PyMOL 
version 0.97 (26) or XtalView (23). 
 
6-3. Results 
6-3-1. Expression and purification of saccharopine reductase 
The SR produced in the BL21-Star(DE3)-RIL cells using the pET expression 
system was very high, about 22% of the total soluble proteins. The elution profile of 
SR from the Ni-NTA column shows that the enzyme begins to elute at an imidazole 
concentration of 90 mM with the highest concentration in fractions eluted between 
150 and 180 mM imidazole (data not shown). The purity of the eluted SR was 
estimated to be ≥ 98% based on Coomassie-stained SDS-PAGE gels (see Appendix – 
Fig. A-13). The amount of purified enzyme obtained is 10-12 mg from 150 mL of cell 
culture. 
 
6-3-2. Protein crystallization 
No crystals were observed using Crystal Screen kit and Crystal Screen 2 kit from 
Hampton Research. Further studies showed that these sparse matrix screens do not 
contain the minimal appropriate conditions (see below) for promotion of the crystal 
growth. 
Home-made screen #1 did not show any sign of crystal growth. However, 
diffraction-quality single crystals were obtained using home-made screen #2 (see 
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 Appendix – Fig. A-14). Crystals usually appeared within 5-7 days with average 
dimensions of 0.14 × 0.14 × 0.18 mm. The diffraction quality single crystals can be 
morphologically categorized as truncated hexagonal prisms (see Appendix – Fig. A-
15). Checking the final pH of the screening solutions (as an additional internal 
control), showed that SR crystallizes within a narrow pH range of 7.0-7.5, with the 
highest number of single crystals obtained in 50 mM Bis-Tris (pH 7.2) containing 2.4 
M ammonium sulfate. Using home-made screen #3, a pH range of 7.0-7.5 and 
ammonium sulfate concentration of 2.4-2.5 M and freshly purified enzyme appeared 
to be optimal for crystallization of SR. 
 
6-3-3. Activity 
To check the activity of the crystallized enzyme, four medium-sized crystals were 
transferred to the mother liquor for washing. The crystals were then dissolved in 100 
mM Tris buffer (pH 9.0) and used for enzyme assay. The SR enzyme remains active in 
crystalline form at room temperature for a long period. The results of an enzyme assay 
(14) performed on crystals 60 days after the preparation of the crystallization screen, 
showed that the enzyme in crystalline form was almost as active as the enzyme stored 
at -80 °C. Under the conditions used for enzyme assay, specific activities of 2.6 and 
4.0 U/mg were calculated for the enzyme that was in the crystalline form and the 
enzyme solution stored at -80 °C, respectively. 
 
6-3-4. Data collection and processing 
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 Initial processing of the dataset revealed that four possible trigonal space groups 
(P31, P32, P3121, P3221) should be considered. The data collection statistics seemed 
reasonable when processed in these space groups and all four space groups represent 
the general l = 3n reflection condition that was obvious as systematic absences in the 
scaled reflection file. Space groups P32 and P3221 were ruled out as they did not give 
reasonable molecular replacement solutions. Molecular replacement and model 
refinement were successful in the P3121 and P31 space groups with the asymmetric 
unit as a monomer or dimer, respectively. In the case of the P31 space group, the SR 
dimer interface is coincident with a crystallographic axis in the P3121 space group. 
Therefore, the higher symmetry space group (P3121) with the asymmetric unit as 
monomer was the space group of choice (Table 6-1). In this case, the crystal packing 
shows the dimeric form of the SR. A Matthews’ coefficient (27) of 2.90 Å3/Da was 
calculated for both space groups (asymmetric unit as dimer for P31 and as a monomer 
for P3121) corresponding to a solvent content of 57.5%. 
Table 6-1: Summary of data collection statistics 
Space group P31 P3121 
a = b (Å) 85.28 85.28 
c (Å) 141.97 141.98 
Resolution (Å) 40.0-1.70 40.0-1.70 
Number of observations 459,467 465,261 
Unique reflections 120,831 64,787 
Completeness (%) 95.1 (92.3)b 97.6 (95.9) 
Mean I/σ(I) 12.7 (3.2) 15.8 (4.3) 
Rsyma (%) 5.2 (28.3) 5.6 (36.8) 
a 
( )( )∑∑
−=
j
jj
sym I
II
R , where jI  is the intensity measurement for a given reflection, and jI  is the 
average intensity for multiple measurements of this reflection. 
b Values in parentheses correspond to the highest resolution shell (1.76-1.70 Å). 
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 6-3-5. Molecular replacement, model building, structure refinement and 
validation 
As shown in Table 6-2, the value of LLG (Log-Likelihood Gain) as reported by 
the Phaser program is an indication of the success of a candidate model used for 
macromolecular phasing in a specific space group. No solution could be found for 
either P32 or P3221 space groups suggesting that P31 and P3121 were the most 
probable space groups. In the case of the P3121 space group, the initial model had an 
R factor of 51.5% (Rfree = 50.3%) and 434 out of 446 residues were built in 6 chains at 
the end of cycle eight with a connectivity index of 0.97 and an R factor of 19.4% (Rfree 
= 28.7%). Missing residues were built using XtalView and four sulfate anions were 
added to positions with high Fo-Fc electron density and proper geometry. The first 
methionine residue of the protein as well as the 21 residue deca-histidine tag could not 
be built because of missing electron density. Also, part of the electron density for the 
side chains of the surface-located residues Phe12 and Lys44 is missing. The final 
model was refined using REFMAC. The final protein model, which is the monomer 
form (P3121) contains 445 residues, 349 water molecules and 4 sulfate anions. Pro126 
and Pro414 adopt a cis conformation and surprisingly, Trp173 was also found to be in 
cis conformation (see below). The refinement statistics of the final model are 
summarized in Table 6-3. 
Table 6-2: Results of molecular replacement 
Space group Asymmetric unit LLGa (Initial) LLG (Refined) 
P31 Dimer 619.26 685.19 
P3121 Monomer 332.69 366.24 
a LLG: Log-Likelihood Gain. 
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 Table 6-3: Summary of the refinement statistics for the P3121 space group. 
Resolution (Å) 40.0-1.70 
Rcryst (Rfreea) (%) 19.8 (24.0) 
Avg. B factor (all) (Å2) 26.7 
Avg. B factor (main) (Å2) 25.2 
Avg. B factor (side) (Å2) 28.3 
Asymmetric unit Monomer 
No. of protein atoms 3444 
No. of solvent molecules  (349 H2O + 4 SO42-) 
RMS deviation 
Bond length (Å) 0.014 
Bond angle (°) 1.41 
Ramachandran plot (% residues in) 
Most favored regions 94.4 
Additional allowed regions 5.6 
Generously allowed regions 0.0 
Disallowed regions 0.0 
aRfree was calculated using 5% of the diffraction data. 
 
6-3-6. Overall structure 
Similar to the enzyme from M. grisea (3), the SR from S. cerevisiae folds into 
three domains. The overall structure of the enzyme and a topology diagram 
(www.tops.leeds.ac.uk) is presented in Fig. 6-1. Domain I (residues 1-124 and 387-
438), which is a variant of Rossmann fold (12), consists of a seven-stranded β-sheet 
(β1-6 and β15), sandwiched between three helices (α3-5) on one side and four helices 
(α1-2, α17-18) on the other side. Domain II (residues 125-247, 351-386, 439-446) 
which is composed of an α/β fold, contains a central seven-stranded mixed β-sheet 
(β7-9, β12-14 and β16). The β-sheet of domain II is surrounded by helices α6 and α10 
on one side and helices α7-9, and strands β10-11 on the other side. The loop 
connecting the β10 and β11 strands is involved in dimer interaction. Domain II has a 
169
 unique fold that is known as saccharopine reductase fold (3). Domain III (residues 
248-350) is an all-helical domain composed of helices α11-16. 
The dimer interface for the SR from S. cerevisiae is similar to the interface 
reported for the SR from M. grisea (3) (Fig. 6-2A). The two subunits of the 
homodimer enzyme are related by twofold symmetry. The interface residues consist of 
45% polar and 55% nonpolar residues. The loop connecting the β10 and β11 strands 
has the highest contribution to the dimer interface interaction (Fig. 6-2B). Also, the 
residues from helices α7 and α15, and β strands β14 and β16 participate in dimer 
interface interactions. The total buried surface area in both subunits is 2213 Å2 
(calculated using a probe with a radius of 1.4 Å) 
(www.biochem.ucl.ac.uk/bsm/PP/server), which is 5.6% of the total surface area of 
the enzyme. Fourteen hydrogen bonds are responsible for the subunit-subunit 
interactions in the homodimer enzyme molecule (Table 6-4). 
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 Table 6-4: Hydrogen bond interactions in homodimer interface 
Subunit A/Subunit B intermolecular contacts (hydrogen bond interactionsa) 
Chain A residues Location Chain B residues Location Distance (Å) 
Glu161 Oε1 α7 Tyr382 Oη β14: C-term 2.91 
Ser163 Oγ α7 Gly214 N β10-11 loop 2.97 
Asp164 Oδ2 α7 Lys443 Nζ β16: C-term 2.71 
Pro213 O β10-11 loop Gln248 Nε2 β12: C-term 2.98 
Gly214 N β10-11 loop Ser163 Oγ α7 3.00 
Gly214 O β10-11 loop Ala216 N β10-11 loop 2.96 
Tyr215 O β10-11 loop Gln248 Nε2 β12: C-term 2.70 
Ala216 N β10-11 loop Gly214 O β10-11 loop 3.03 
Gln248 Nε2 β12: C-term Tyr215 O β10-11 loop 2.81 
Gln248 Nε2 β12: C-term Pro213 O β10-11 loop 2.93 
Ser316 Oγ α15 Ala446 O β16: C-term 2.84 
Arg354 Nη2 β13: N-term Arg354 Nη2 β13: N-term 2.94 
Tyr382 Oη β14: C-term Glu161 Oε1 α7 2.90 
Ala446 O β16: C-term Ser316 Oγ α15 2.88 
aIdentified using the CONTACT program implemented in CCP4 program suite with donor-
acceptance cutoff distance of ≤3.2 Å, and by visual inspection. 
 
6-4. Discussion 
On the basis of structural comparisons and alignment between the SR from S. 
cerevisiae and the SR from M. grisea, the two structures have small differences in the 
relative positions of the domains (Fig. 6-3). The superposition of the two apo enzymes 
(performed using LSQKAB implemented in the CCP4 program suite (22)) yields a 
main chain RMS displacement of 4.7 Å. Individual domain superposition for domains 
I, II, and III give the RMS values of 4.8, 4.1 and 3.5 Å, respectively. The molecular 
packing of SR in space group P3121 brings part of domain II from one SR molecule 
into close proximity of the active site of another SR molecule resulting in the active 
site being partially buried. This kind of interaction is different from the molecular 
packing interaction observed for SR from M. grisea in space group C2221 in which the 
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 active site is completely open to solvent (3). The relative location of the active site 
based on SR from M. grisea is shown in Fig. 6-3. 
 
In the S. cerevisiae SR, Trp173 is in close contact with Gly144 from a symmetry-
related molecule suggesting that the cis conformation of Trp173 is an induced 
conformation, due to close molecular packing in the P3121 space group. In the 
structure of the SR from M. grisea trans-Trp174 is the equivalent residue to the 
Trp173 of the SR from S. cerevisiae. The two amino acids can be superposed at the 
same location in terms of the structural position. However, the side chain 
conformation of the two amino acids is different (Fig. 6-4). It has been reported that in 
the case of the SR from M. grisea, Trp174 forms a hydrophobic contact against the 
active site allowing the enzymatic reaction to occur. Trp174 is also in close contact to 
Domain I
Domain II
Domain III
Active site
Domain I
Domain II
Domain III
Active site
Fig. 6-3: Stereoview of structural superposition of the apo-SR molecules from M. grisea (yellow) 
and S. cerevisiae (blue). Overall RMS deviation for main chain atoms is 4.7 Å. The position of the 
active site of the SR from M. grisea is also shown (blue oval). 
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 Trp174
Trp173
Gly156
Gly157
Arg246
Arg247
Gly144
Ala143
the nicotinamide ring of the NADPH thus influencing the geometric position of the 
cofactor (3). 
 
 
The cis-Pro126 of SR from S. cerevisiae is equivalent to cis-Pro127 of SR from 
M. grisea. The carbonyl group of the Pro127 forms a hydrogen bond to the amine 
Fig. 6-4: Structural superposition of the apo-SR molecules from M. grisea (yellow) and S. cerevisiae
(blue) focusing on the positions of Trp173 and Trp174. Trp174 (M. grisea) maintains a trans
conformation while Trp173 (S. cerevisiae) exists as an induced cis conformation due to the 
molecular packing interactions. The interaction between Trp173 and the residues (Ala 143 and Gly
144) from a symmetry-related SR molecule is also shown. 
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 group of the amide of the nicotinamide ring of the NADPH which requires the proline 
to be in cis conformation (3). A similar role is suggested for the Pro126 of the SR 
from S. cerevisiae. These two prolines are located in the same structural position when 
the two SR enzymes are superposed. cis-Pro414 is part of a loop in domain I 
connecting the helix α17 to strand β15 .The equivalent residue to cis-Pro414 in the SR 
from M. grisea is Arg418. The functional role of this replacement is unknown. 
The ternary complex of the SR from M. grisea with the bound saccharopine and 
NADPH, shows that Arg247, Arg224, and Ser99 interact with the carboxylate of the 
lysine moiety of saccharopine, carboxylate of the glutamate moiety of saccharopine, 
and side chain carboxylate of the glutamate moiety of saccharopine, respectively (3). 
The same roles in binding to saccharopine are suggested for the Arg246, Arg223, and 
Ser98 residues for the SR from S. cerevisiae. As shown in Fig. 6-5, the residues 
involved in the active site of the SR from M. grisea superpose very well to their 
equivalent residues in the SR from S. cerevisiae, strongly suggesting that the same 
residues are involved in forming the active site of SR from S. cerevisiae. The largest 
difference is in the side chain positions of Tyr99 and Tyr100. However, since the main 
chain of the Tyr residues are involved in substrate (saccharopine) binding (3), the 
difference in side chain position does not seem to be significant. 
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Fig. 6, shows the superposition of the NADPH:Saccharopine:Enzyme ternary 
complex from M. grisea to the apo enzyme from S. cerevisiae (main chain RMS: 4.7 
Å) suggesting that the substrates (saccharopine and NADPH) may bind in a similar 
manner to the active site of the enzyme from S. cerevisiae. 
Ser98
Ser99
Asp126
Asp125
Tyr99
Tyr100
Gly157
Gly156
Thr245
Thr244
Arg223
Arg224
Arg246
Arg247
Fig. 6-5: Structural superposition of the apo-SR molecules from M. grisea (yellow) and S. cerevisiae
(blue) focusing on the residues around the active site. The relative spatial positions of the residues
and side chain orientation involved in the active site are well conserved. 
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 Four sulfate anions (per monomer), likely originating from the crystallization 
solution, interact with residues of SR from S. cerevisiae (Fig. 6-7). Three of the four 
sulfate molecules are positioned to occupy the saccharopine carboxylate binding sites 
of SR from M. grisea. Arg246 interacts with one sulfate molecule as indicated by a 
very well-defined electron density for the sulfate. Arg246 is inside a hydrophobic core 
surrounded by Tyr169, Phe250, Val178, and Leu167 contributing to the rigidity of the 
Arg side chain that facilitate its interaction with sulfate molecule. A tetrahedral-shaped 
electron density map was interpreted as the second sulfate molecule interacting with 
Ser98 and the main chain nitrogen of Tyr77 (relative occupancy of 50%) (not shown). 
The third sulfate molecule interacts with both Arg223 and Arg242 with a relative 
occupancy of 50% (not shown). The fourth sulfate molecule (50% relative occupancy) 
binds in a position that brings together the side chains of the Arg354 from both chains 
A and B (not shown). The side chain of Arg354 from both chains A and B exist as two 
conformers. 
Mapping the non-conserved residues between the SRs from M. grisea and S. 
cerevisiae, shows that a total of 92 out of 446 amino acids (21%) are different (Fig. 6-
8). In terms of individual domains, 42 out of 176 residues differ within domain I 
(24%), 24 out of 167 residues are different within domain II (14%), and 26 out 103 
residues differ within domain III (25%). Domain II shows the highest degree of 
conserved residues, suggesting that the fold is important for proper substrate binding 
as well as to keep the domain I and domain III in an appropriate spatial orientation for 
closing and opening the active site. However, the residues that differ do not impose 
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 any significant change to the total accessible surface area (calculated using AREAMOL 
Sulfate
Arg246 A
Phe250 A
Phe171 A
Tyr169 A
Leu167 A
Fig. 6-7: Electron density of a sulfate molecules in the vicinity of Arg246. This residue has a rigid
side chain because of the surrounding hydrophobic residues and hydrogen bond interactions to the
sulfate molecule (Blue, 1σ; Pink, 3σ; Red, 5σ). 
Domain I Domain III
Domain II
Fig. 6-8: Location of the non-conserved residues between SRs from S. cerevisiae vs. M. grisea. 
Areas depicted in red represent non-conserved residues. Domain II has the highest ratio of
conserved residues. 
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 implemented in the CCP4 program suite (22)) for the apo SRs, which are 19,789 and 
19,680 Å2, for the enzymes from S. cerevisiae and M. grisea, respectively. 
Most of the enzymes similar to saccharopine reductase from S. cerevisiae and M. 
grisea belong to the aspartate family of amino acid biosynthesis pathways suggesting 
that some of these enzymes evolved from a common ancestor (3). The SR from S. 
cerevisiae shares significant similarities to the SR from M. grisea suggesting that the 
same evolutionary pathways are applicable in this case. The uniqueness of the α-
aminoadipate pathway for the biosynthesis of lysine, make it a potential pathway for 
the structure-based drug design once the three-dimensional structures of the enzymes 
are in hand. The known structures of the saccharopine reductases from M. grisea (3) 
and S. cerevisiae could be the starting point for this endeavor. 
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 APPENDIX 
CoA-SH + DCPIPox + H20 → DCPIPred + CoA-S-OH   (1:1 stoichiometry)    
2CoA-SH + DCPIPox → DCPIPred + CoA-S-S-CoA (2:1 stoichiometry)
2CoA-S-OH ↔ CoA-SO-S-CoA + H2O   
(New form of CoA)
2CoA-S-OH ↔ CoA-S-S-CoA + H2O2
(Oxidized form of CoA)
0.1 mM DCPIP + 0.05 mM CoASH
∆C of DCPIP = 0.05 mM
↔
DCPIPox
http://www.biology.ucsc.edu
DCPIPred
Fig. A-1: Stoichiometry of the reaction of DCPIP with CoA based on the spectroscopic assay. 
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day. 
Fig. A-4: Initial velocity double-reciprocal plot for the HCS reaction using OAA as substrate. The 
concentrations of AcCoA are as plotted, while OAA is fixed at 50 mM (◆), 21.4 mM (■), 13.6 mM 
(▲), and 10 mM (●). The solid lines are drawn based on a fit to eq. 3, while the points are 
experimental. 
0
0.5
1
1.5
2
2.5
-170 -120 -70 -20 30 80
1/
v 
(m
in
/µ
M
)
1/[Acetyl-CoA] (mM-1)
1/
v 
(m
in
/µ
M
)
187
 0
0.
51
1.
52
2.
53
3.
54
4.
55
0
0.
2
0.
4
0.
6
0.
8
1
0
0.
51
1.
52
2.
53
3.
54
4.
55
-1
0
1
2
3
4
5
6
1/
KG
 (m
M
-1
)
1/v (min/µM)
Ly
si
ne
 (m
M
)
Slope
A
B
0
0.
51
1.
52
2.
53
3.
54
4.
55
0
0.
2
0.
4
0.
6
0.
8
1
0
0.
51
1.
52
2.
53
3.
54
4.
55
-1
0
1
2
3
4
5
6
1/
KG
 (m
M
-1
)
Ly
si
ne
 (m
M
)
A
B
Fi
g.
 A
-5
: 
A
. I
nh
ib
iti
on
 o
f 
H
C
S 
by
 ly
sin
e.
 C
on
ce
nt
ra
tio
ns
 o
f 
K
G
 a
re
 a
s 
pl
ot
te
d,
 w
hi
le
 A
cC
oA
 is
 f
ix
ed
 a
t 
0.
5 
m
M
. L
ys
in
e 
co
nc
en
tr
at
io
ns
 a
re
 a
s 
fo
llo
w
s:
 0
 m
M
 (◆
), 
0.
25
 m
M
 (■
), 
0.
5 
m
M
 (▲
), 
1.
0 
m
M
 (●
), 
1.
5 
m
M
 (◊
), 
2.
0 
m
M
 ( 
), 
3.
0 
m
M
 (∆
), 
4.
0 
m
M
 (○
), 
5.
0 
m
M
 (×
), 
an
d 
6 
m
M
 (+
). 
T
he
 so
lid
 
lin
es
 a
re
 d
ra
w
n 
ba
se
d 
on
 th
e 
gr
ap
hi
ca
l a
na
ly
sis
, w
hi
le
 th
e 
po
in
ts
 a
re
 e
xp
er
im
en
ta
l. 
B
. T
he
 sl
op
e 
of
 th
e 
lin
es
 in
 A
 v
s l
ys
in
e 
co
nc
en
tr
at
io
n 
sh
ow
in
g 
a
lin
ea
r 
in
hi
bi
tio
n 
w
ith
 a
 K
i l
ys
 o
f 0
.5
 m
M
. 
 
188
 0
0.
51
1.
52
2.
53
3.
54
4.
5
-6
0
-4
0
-2
0
0
20
40
60
80
1/
[A
ce
ty
l-C
oA
] (
m
M
-1
)
1/v (min/µM)
-0
.500.
51
1.
52
2.
5
-1
00
-8
0
-6
0
-4
0
-2
0
0
20
40
60
80
1/
[A
ce
ty
l-C
oA
](m
M
-1
)
1/v (min/µM)
0
0.
51
1.
52
2.
53
3.
5
-4
0
-2
0
0
20
40
60
80
1/
[A
ce
ty
l-C
oA
] (
m
M
-1
)
1/v (min/µM)
01234567
-2
0
0
20
40
60
80
1/
[A
ce
ty
l-C
oA
] (
m
M
-1
)
1/v (min/µM)
A
D
C
B
0
0.
51
1.
52
2.
53
3.
54
4.
5
-6
0
-4
0
-2
0
0
20
40
60
80
1/
[A
ce
ty
l-C
oA
] (
m
M
-1
)
-0
.500.
51
1.
52
2.
5
-1
00
-8
0
-6
0
-4
0
-2
0
0
20
40
60
80
1/
[A
ce
ty
l-C
oA
](m
M
-1
)
0
0.
51
1.
52
2.
53
3.
5
-4
0
-2
0
0
20
40
60
80
1/
[A
ce
ty
l-C
oA
] (
m
M
-1
)
01234567
-2
0
0
20
40
60
80
1/
[A
ce
ty
l-C
oA
] (
m
M
-1
)
A
D
C
B
Fi
g.
 A
-6
: I
ni
tia
l r
at
e 
st
ud
ie
s o
f N
a+
 in
hi
bi
tio
n 
an
d 
ac
tiv
at
io
n.
 D
ou
bl
e 
re
ci
pr
oc
al
 in
iti
al
 v
el
oc
ity
 p
at
te
rn
s v
ar
yi
ng
 A
cC
oA
 a
t d
iff
er
en
t f
ix
ed
 le
ve
ls
 o
f 
α-K
g:
 1
 m
M
 (●
), 
1.
46
 m
M
 (▲
), 
2.
5 
m
M
 (■
), 
an
d 
10
 m
M
 (◆
) w
er
e 
m
ea
su
re
d 
in
 5
0 
m
M
 H
ep
es
, p
H
 7
.5
 a
nd
 2
5o
C
 in
 th
e 
pr
es
en
ce
 o
f t
he
 fo
llo
w
in
g 
N
a+
 c
on
ce
nt
ra
tio
ns
: (
A
) 0
 m
M
, (
B
) 2
5 
m
M
, (
C
) 1
00
 m
M
, a
nd
 (D
) 2
50
 m
M
. P
oi
nt
s a
re
 e
xp
er
im
en
ta
l, 
w
hi
le
 th
e
so
lid
 li
ne
s a
re
 th
eo
re
tic
al
 b
as
ed
 o
n 
a 
fit
to
eq
3.
189
 0
0.
2
0.
4
0.
6
0.
81
1.
2
1.
4
1.
6
1.
8
0
0.
1
0.
2
0.
3
0.
4
0.
5
0.
6
0.
7
0.
8
0.
9
1
1/
[α
-K
et
og
lu
ta
ra
te
](m
M
-1
)
Intercept
B
0
0.
01
0.
02
0.
03
0.
04
0.
05
0.
06
0.
07
0
0.
1
0.
2
0.
3
0.
4
0.
5
0.
6
0.
7
0.
8
0.
9
1
1/
[α
-K
et
og
lu
ta
ra
te
](m
M
-1
)
Slope
A
0
0.
2
0.
4
0.
6
0.
81
1.
2
1.
4
1.
6
1.
8
0
0.
1
0.
2
0.
3
0.
4
0.
5
0.
6
0.
7
0.
8
0.
9
1
1/
[α
-K
et
og
lu
ta
ra
te
](m
M
-1
)
B
0
0.
01
0.
02
0.
03
0.
04
0.
05
0.
06
0.
07
0
0.
1
0.
2
0.
3
0.
4
0.
5
0.
6
0.
7
0.
8
0.
9
1
1/
[α
-K
et
og
lu
ta
ra
te
](m
M
-1
)
A
Fi
g.
 A
-7
: S
ec
on
da
ry
 r
ep
lo
ts
 o
f t
he
 d
at
a 
in
 F
ig
. A
-6
. A
. S
lo
pe
 r
ep
lo
t c
on
st
ru
ct
ed
 fr
om
 th
e 
slo
pe
 o
f t
he
 li
ne
s i
n 
Fi
gs
. A
-6
A
-D
 v
s. 
re
ci
pr
oc
al
 o
f α
-K
g 
co
nc
en
tr
at
io
n 
at
 e
ac
h 
of
 th
e 
N
a+
 c
on
ce
nt
ra
tio
ns
 in
di
ca
te
d 
in
 F
ig
. A
-6
A
-D
. B
. I
nt
er
ce
pt
 r
ep
lo
t c
on
st
ru
ct
ed
 fr
om
 th
e 
in
te
rc
ep
t v
s. 
re
ci
pr
oc
al
 o
f α
-
K
g 
co
nc
en
tr
at
io
n 
as
 in
 A
. P
oi
nt
s a
re
 fr
om
 a
 g
ra
ph
ic
al
 a
na
ly
sis
, w
hi
le
 th
e 
so
lid
 li
ne
s i
n 
A
 a
nd
 B
 a
re
 th
eo
re
tic
al
 b
as
ed
 o
n 
a 
fit
 to
 e
q 
3 
(C
ha
pt
er
 4
).
 
190
 Fi
g.
 A
-8
: P
C
R
 fo
r 
th
e 
LY
S9
 g
en
e 
(1
34
1 
bp
) f
ro
m
 S
ac
ch
ar
om
yc
es
 c
er
ev
isi
ae
 a
nd
 g
el
 p
ur
ifi
ca
tio
n.
 T
he
 P
C
R
 p
ro
du
ct
 is
 1
38
0 
bp
. 
191
 Fi
g.
 A
-9
: L
YS
9-
pU
C
12
 c
lo
ni
ng
 v
ec
to
r 
(4
06
0 
bp
). 
N
de
 I 
an
d 
Xh
o 
I c
ut
 L
YS
9 
se
gm
en
t i
s 1
35
4 
bp
. 
192
 Fi
g.
 A
-1
0:
 C
on
st
ru
ct
io
n 
of
 th
e 
LY
S9
-p
U
C
12
 c
lo
ni
ng
 v
ec
to
r.
 
193
 Fi
g.
 A
-1
1:
 L
YS
9-
pE
T-
16
b 
ex
pr
es
sio
n 
ve
ct
or
 (7
06
5 
bp
). 
N
de
 I 
an
d 
Xh
o 
I c
ut
 v
ec
to
r 
sh
ow
s t
he
 L
YS
9 
in
se
rt
 (l
an
e 
6)
. 
194
 Fi
g.
 A
-1
2:
 S
eq
ue
nc
in
g 
of
 th
e 
LY
S9
 fr
ag
m
en
t o
f t
he
 L
YS
9-
pE
T-
16
b 
ex
pr
es
sio
n 
ve
ct
or
. T
he
 se
qu
en
ce
 o
f t
he
 2
1 
am
in
o 
ac
id
 in
 th
e 
H
is-
ta
g 
is 
sh
ow
n.
 T
he
 a
rr
ow
 sh
ow
s t
he
 b
eg
in
ni
ng
 o
f t
he
 L
YS
9 
ge
ne
. 
D
ec
aH
is
-ta
g
LY
S9
 g
en
e 
(S
R
)
h
tt
p:
//
h
tt
p:
//
w
w
w
.n
ov
ag
en
.c
om
w
w
w
.n
ov
ag
en
.c
om
N
de
I s
ite
M
ic
ro
ge
n,
 U
ni
ve
rs
ity
 o
f O
kl
ah
om
a 
H
ea
lth
 S
ci
en
ce
s 
C
en
te
r
D
ec
aH
is
-ta
g
LY
S9
 g
en
e 
(S
R
)
h
tt
p:
//
h
tt
p:
//
w
w
w
.n
ov
ag
en
.c
om
w
w
w
.n
ov
ag
en
.c
om
N
de
I s
ite
M
ic
ro
ge
n,
 U
ni
ve
rs
ity
 o
f O
kl
ah
om
a 
H
ea
lth
 S
ci
en
ce
s 
C
en
te
r
195
 Fi
g.
 A
-1
3:
 P
ur
ifi
ca
tio
n 
of
 th
e 
SR
 u
si
ng
 N
i-N
T
A
 r
es
in
. T
he
 e
nz
ym
e 
is 
m
or
e 
th
an
 9
8%
 p
ur
e 
ba
se
d 
on
 th
e 
C
oo
m
as
si
e-
bl
ue
 st
ai
ni
ng
. 
SR
>9
8 
pu
re
!
Wa
sh
 bu
ffe
r (
60
 m
M 
Im
ida
zo
le)
Flo
w 
thr
ou
gh
Ce
ll e
xtr
ac
t
St
d m
ark
ers
2997 66 4511
6
20
5
kD
a
196
 Fi
g.
 A
-1
4:
 S
in
gl
e 
cr
ys
ta
ls 
of
 S
R
 fr
om
 S
ac
ch
ar
om
yc
es
 c
er
ev
isi
ae
 fr
om
 d
iff
er
en
t v
ie
w
s. 
C
ry
st
al
s c
an
 b
e 
m
or
ph
ol
og
ic
al
ly
 
ca
te
go
ri
ze
d 
as
 tr
un
ca
te
d 
he
xa
go
na
l p
ri
sm
. 
197
 Fi
g.
 A
-1
5:
 D
im
en
sio
ns
 o
f t
he
 S
R
 c
ry
st
al
 u
se
d 
fo
r 
da
ta
 c
ol
le
ct
io
n.
 A
ve
ra
ge
 d
im
en
sio
ns
 o
f t
he
 c
ry
st
al
 is
 0
.1
4 
× 
0.
14
 ×
 0
.1
8 
m
m
. 
0.
12
 m
m
0.1
8 m
m
0.
04
 m
m
0.
14
 m
m
0.
16
 m
m
D
im
en
si
on
s 
of
 th
e 
SR
 
cr
ys
ta
l u
se
d 
fo
r d
at
a 
co
lle
ct
io
n
Av
g.
 d
im
en
si
on
:
0.
14
 x
0.
14
 x
0.
18
 m
m
198
 Fi
g.
 A
-1
6:
 R
ef
le
ct
io
n 
im
ag
es
 o
f t
he
 S
R
 c
ry
st
al
s t
ak
en
 a
t d
iff
er
en
t c
ry
st
al
 o
ri
en
ta
tio
ns
. 
Im
ag
e 
1
Im
ag
e 
20
0
Im
ag
e 
10
0
Im
ag
e 
30
0
Im
ag
e 
1
Im
ag
e 
20
0
Im
ag
e 
10
0
Im
ag
e 
30
0
199
 Fi
g.
 A
-1
7:
 S
ch
em
at
ic
 d
ia
gr
am
 fo
r 
th
e 
re
gu
la
tio
n 
m
ec
ha
ni
sm
 o
f H
C
S 
by
 N
a+
 a
nd
 ly
sin
e.
 
200
  
 
 
THE END 
201
